Exact Mass: 268.0727

Exact Mass Matches: 268.0727

Found 500 metabolites which its exact mass value is equals to given mass value 268.0727, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Inosine

9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-3H-purin-6-one

C10H12N4O5 (268.0808)


Inosine, also known as hypoxanthosine or inotin, belongs to the class of organic compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety. Inosine is formed when hypoxanthine is attached to a ribose ring a beta-N9-glycosidic bond. Inosine is an intermediate in the degradation of purines and purine nucleosides to uric acid. Inosine is also an intermediate in the purine salvage pathway. Inosine occurs in the anticodon of certain transfer RNA molecules and is essential for proper translation of the genetic code in wobble base pairs. Inosine exists in all living species, ranging from bacteria to plants to humans. Inosine participates in a number of enzymatic reactions. In particular, inosine can be biosynthesized from inosinic acid through its interaction with the enzyme known as cytosolic purine 5-nucleotidase. In addition, inosine can be converted into hypoxanthine and ribose 1-phosphate through its interaction with the enzyme known as purine nucleoside phosphorylase. Altered levels of inosine have also been associated with purine nucleoside phosphorylase deficiency and xanthinuria type I, both of which are inborn errors of metabolism. Animal studies have suggested that inosine has neuroprotective properties. It has been proposed as a potential treatment for spinal cord injury (PMID: 16317421) and for administration after stroke, as inosine appears to induce axonal rewiring (PMID: 12084941). After ingestion, inosine is metabolized into uric acid, which has been found to be a natural antioxidant and peroxynitrite scavenger. As such, inosine may have potential benefits to patients with multiple sclerosis and Parkinson’s disease (PMID: 19425822). Inosine can also be produced by gut bacteria and appears to have a number of beneficial effects. Inosine, has been shown to activate peroxisome proliferator-activated receptor (PPAR)-gamma signaling in human colon epithelial cells. Furthermore, exogenous treatment of inosine has been found to protect against DSS-induced colitis in rodents by improving adenosine 2A receptor (A2AR)/PPAR-gamma-dependent mucosal barrier functions (PMID: 33820558). Microbiome-derived inosine has also been shown to modulate the response to checkpoint inhibitor immunotherapy in cancer models. In particular, decreased gut barrier function induced by immunotherapy increases systemic translocation of bacterially derived inosine and activates antitumor T cells. The effect of inosine is dependent on T cell expression of the adenosine A2A receptor and requires co-stimulation. Inosine appears to have other roles in non-mammalian system. For instance, it has been found to be an important feed stimulant by itself or in combination with certain amino acids in some species of farmed fish. For example, inosine and inosine-5-monophosphate have been reported as specific feeding stimulants for turbot fry, (Scophthalmus maximus) and Japanese amberjack. Inosine is a purine nucleoside in which hypoxanthine is attached to ribofuranose via a beta-N(9)-glycosidic bond. It has a role as a human metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite and a mouse metabolite. It is a purines D-ribonucleoside and a member of inosines. It is functionally related to a hypoxanthine and a ribofuranose. A purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose. It is an intermediate in the degradation of purines and purine nucleosides to uric acid and in pathways of purine salvage. It also occurs in the anticodon of certain transfer RNA molecules. (Dorland, 28th ed) Inosine is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). Inosine is a natural product found in Fritillaria thunbergii, Cichorium endivia, and other organisms with data available. Inosine is a metabolite found in or produced by Saccharomyces cerevisiae. A purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose. It is an intermediate in the degradation of purines and purine nucleosides to uric acid and in pathways of purine salvage. It also occurs in the anticodon of certain transfer RNA molecules. (Dorland, 28th ed) G - Genito urinary system and sex hormones > G01 - Gynecological antiinfectives and antiseptics > G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06B - Chemotherapeutics for topical use > D06BB - Antivirals A purine nucleoside in which hypoxanthine is attached to ribofuranose via a beta-N(9)-glycosidic bond. COVID info from COVID-19 Disease Map, clinicaltrial, clinicaltrials, clinical trial, clinical trials S - Sensory organs > S01 - Ophthalmologicals Present in meat extracts and sugar beet Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS [Spectral] Inosine (exact mass = 268.08077) and L-Methionine (exact mass = 149.05105) and Adenosine (exact mass = 267.09675) were not completely separated on HPLC under the present analytical conditions as described in AC$XXX. Additionally some of the peaks in this data contains dimers and other unidentified ions. [Spectral] Inosine (exact mass = 268.08077) and L-Tyrosine (exact mass = 181.07389) and Guanosine (exact mass = 283.09167) were not completely separated on HPLC under the present analytical conditions as described in AC$XXX. Additionally some of the peaks in this data contains dimers and other unidentified ions. [Spectral] Inosine (exact mass = 268.08077) and S-Adenosyl-L-homocysteine (exact mass = 384.12159) were not completely separated on HPLC under the present analytical conditions as described in AC$XXX. Additionally some of the peaks in this data contains dimers and other unidentified ions. [Spectral] Inosine (exact mass = 268.08077) and Guanosine (exact mass = 283.09167) were not completely separated on HPLC under the present analytical conditions as described in AC$XXX. Additionally some of the peaks in this data contains dimers and other unidentified ions. Acquisition and generation of the data is financially supported in part by CREST/JST. CONFIDENCE standard compound; INTERNAL_ID 110 KEIO_ID I003 Inosine is an endogenous purine nucleoside produced by catabolism of adenosine. Inosine has anti-inflammatory, antinociceptive, immunomodulatory and neuroprotective effects. Inosine is an agonist for adenosine A1 (A1R) and A2A (A2AR) receptors[1][2][3]. Inosine is an endogenous purine nucleoside produced by catabolism of adenosine. Inosine has anti-inflammatory, antinociceptive, immunomodulatory and neuroprotective effects. Inosine is an agonist for adenosine A1 (A1R) and A2A (A2AR) receptors[1][2][3]. Inosine is an endogenous purine nucleoside produced by catabolism of adenosine. Inosine has anti-inflammatory, antinociceptive, immunomodulatory and neuroprotective effects. Inosine is an agonist for adenosine A1 (A1R) and A2A (A2AR) receptors[1][2][3]. Inosine is an endogenous purine nucleoside produced by catabolism of adenosine. Inosine has anti-inflammatory, antinociceptive, immunomodulatory and neuroprotective effects. Inosine is an agonist for adenosine A1 (A1R) and A2A (A2AR) receptors[1][2][3].

   

Formononetin

7-hydroxy-3-(4-methoxyphenyl)-4H-chromen-4-one

C16H12O4 (268.0736)


Formononetin is a member of the class of 7-hydroxyisoflavones that is 7-hydroxyisoflavone substituted by a methoxy group at position 4. It has a role as a phytoestrogen and a plant metabolite. It is a member of 7-hydroxyisoflavones and a member of 4-methoxyisoflavones. It is functionally related to a daidzein. It is a conjugate acid of a formononetin(1-). Formononetin is under investigation in clinical trial NCT02174666 (Isoflavone Treatment for Postmenopausal Osteopenia.). Formononetin is a natural product found in Pterocarpus indicus, Ardisia paniculata, and other organisms with data available. See also: Astragalus propinquus root (part of); Trifolium pratense flower (part of). Formononetin are abundant in vegetables. It is a phyto-oestrogen that is a polyphenolic non-steroidal plant compound with oestrogen-like biological activity (PMID: 16108819). It can be the source of considerable estrogenic activity (http://www.herbalchem.net/Intermediate.htm). Widespread isoflavone found in soy beans (Glycine max), red clover (Trifolium pratense and chick peas (Cicer arietinum). Potential nutriceutical A member of the class of 7-hydroxyisoflavones that is 7-hydroxyisoflavone substituted by a methoxy group at position 4. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D004967 - Estrogens CONFIDENCE standard compound; INTERNAL_ID 301; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8803; ORIGINAL_PRECURSOR_SCAN_NO 8802 CONFIDENCE standard compound; INTERNAL_ID 301; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8826; ORIGINAL_PRECURSOR_SCAN_NO 8825 CONFIDENCE standard compound; INTERNAL_ID 301; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4484; ORIGINAL_PRECURSOR_SCAN_NO 4480 CONFIDENCE standard compound; INTERNAL_ID 301; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4474; ORIGINAL_PRECURSOR_SCAN_NO 4471 DATA_PROCESSING MERGING RMBmix ver. 0.2.7; CONFIDENCE standard compound; INTERNAL_ID 301; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4474; ORIGINAL_PRECURSOR_SCAN_NO 4470 CONFIDENCE standard compound; INTERNAL_ID 301; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8863; ORIGINAL_PRECURSOR_SCAN_NO 8861 CONFIDENCE standard compound; INTERNAL_ID 301; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4474; ORIGINAL_PRECURSOR_SCAN_NO 4470 CONFIDENCE standard compound; INTERNAL_ID 301; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8847; ORIGINAL_PRECURSOR_SCAN_NO 8844 CONFIDENCE standard compound; INTERNAL_ID 301; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8852; ORIGINAL_PRECURSOR_SCAN_NO 8851 CONFIDENCE standard compound; INTERNAL_ID 301; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8822; ORIGINAL_PRECURSOR_SCAN_NO 8821 CONFIDENCE standard compound; INTERNAL_ID 301; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4569; ORIGINAL_PRECURSOR_SCAN_NO 4566 CONFIDENCE standard compound; INTERNAL_ID 301; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4507; ORIGINAL_PRECURSOR_SCAN_NO 4504 Acquisition and generation of the data is financially supported in part by CREST/JST. INTERNAL_ID 2291; CONFIDENCE Reference Standard (Level 1) CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2291 IPB_RECORD: 481; CONFIDENCE confident structure Formononetin is a potent FGFR2 inhibitor with an IC50 of ~4.31 μM. Formononetin potently inhibits angiogenesis and tumor growth[1]. Formononetin is a potent FGFR2 inhibitor with an IC50 of ~4.31 μM. Formononetin potently inhibits angiogenesis and tumor growth[1].

   

DL-Homocystine

2-amino-4-[(3-amino-3-carboxypropyl)disulfanyl]butanoic acid

C8H16N2O4S2 (268.0551)


Homocystine is the oxidized form of homocysteine. Homocystine is a dipeptide consisting of two homocysteine molecules joined by a disulfide bond. Homocysteine is a sulfur-containing amino acid that arises during methionine metabolism. Homocystine occurs only transiently before being reduced to homocysteine and converted to the harmless cystathionine via a vitamin B6-dependent enzyme. Homocystine and homocysteine-cysteine mixed disulfides account for >98\\\\\% of total homocysteine in plasma from healthy individuals (PMID 11592966). Homocystine has been shown to stereospecifically induce endothelial nitric oxide synthase-dependent lipid peroxidation in endothelial cells, thereby inducing a vascular cell type-specific oxidative stress. This vascular stress is associated with atherothrombotic cardiovascular disease (PMID: 14980706). High levels of homocysteine (and homocysteine) can be found in individuals suffering from homocystinura due to cystathionine synthase deficiency (PMID: 4685596) Homocystine is the double-bonded form of homocysteine, but it occurs only transiently before being converted to the harmless cystathionine via a vitamin B6-dependent enzyme. Acquisition and generation of the data is financially supported in part by CREST/JST. KEIO_ID H041 4,4'-Disulfanediylbis(2-aminobutanoic acid) is an endogenous metabolite. DL-Homocystine is the double-bonded form of homocysteine and homocysteine is recognized as an important substance in the pathogenesis and pathophysiology of schizophrenia. L-Homocystine is the oxidized member of the L-homocysteine. Homocysteine is a pro-thrombotic factor, vasodilation impairing agent, pro-inflammatory factor and endoplasmatic reticulum-stress inducer used to study cardiovascular disease mechanisms.

   

Tectochrysin

4H-1-Benzopyran-4-one, 5-hydroxy-7-methoxy-2-phenyl- (9CI)

C16H12O4 (268.0736)


7-methylchrysin, also known as 5-hydroxy-7-methoxyflavone or techtochrysin, is a member of the class of compounds known as 7-o-methylated flavonoids. 7-o-methylated flavonoids are flavonoids with methoxy groups attached to the C7 atom of the flavonoid backbone. Thus, 7-methylchrysin is considered to be a flavonoid lipid molecule. 7-methylchrysin is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 7-methylchrysin can be found in pine nut, prunus (cherry, plum), sour cherry, and sweet cherry, which makes 7-methylchrysin a potential biomarker for the consumption of these food products. relative retention time with respect to 9-anthracene Carboxylic Acid is 1.330 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.324 Tectochrysin (Techtochrysin) is one of the major flavonoids of Alpinia oxyphylla Miquel. Tectochrysin inhibits activity of NF-κB. Tectochrysin (Techtochrysin) is one of the major flavonoids of Alpinia oxyphylla Miquel. Tectochrysin inhibits activity of NF-κB.

   

3-Hydroxybenzo(a)pyrene

pentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1(18),2,4,6,8,10,12,14,16,19-decaen-13-ol

C20H12O (268.0888)


CONFIDENCE standard compound; INTERNAL_ID 45

   

Dalbergin

6-hydroxy-7-methoxy-4-phenyl-2H-chromen-2-one

C16H12O4 (268.0736)


A polyphenol metabolite detected in biological fluids [PhenolExplorer]

   

Glycine-betaxanthin

(2S,4E)-4-[(2Z)-2-[(carboxymethyl)imino]ethylidene]-1,2,3,4-tetrahydropyridine-2,6-dicarboxylic acid

C11H12N2O6 (268.0695)


   

alpha-Mannosylglycerate

2-O-(alpha-D-Mannopyranosyl)-D-glycerate

C9H16O9 (268.0794)


   

Saphenic acid

6-[(1R)-1-hydroxyethyl]phenazine-1-carboxylic acid

C15H12N2O3 (268.0848)


   

Isoformononetin

3-(4-Hydroxyphenyl)-7-methoxy-4H-chromen-4-one

C16H12O4 (268.0736)


Isoformononetin is found in pulses. Isoformononetin is isolated from soybean (Glycine max) and other plants. Isolated from soybean (Glycine max) and other plants. Isoformononetin is found in soy bean and pulses. Isoformononetin is an analog of Daidzein (HY-N0019) and has immunoprotective effects. Isoformononetin inhibits the differentiation of Th17 and B-cells lymphopoesis to promote osteogenesis in estrogen-deficient bone loss conditions[1]. Isoformononetin is an analog of Daidzein (HY-N0019) and has immunoprotective effects. Isoformononetin inhibits the differentiation of Th17 and B-cells lymphopoesis to promote osteogenesis in estrogen-deficient bone loss conditions[1].

   

2-Hydroxybenzo(a)pyrene

2-Hydroxybenzo(a)pyrene

C20H12O (268.0888)


   

9-Hydroxybenzo[a]pyrene

pentacyclo[10.6.2.0^{2,7}.0^{9,19}.0^{16,20}]icosa-1,3,5,7,9(19),10,12(20),13,15,17-decaen-4-ol

C20H12O (268.0888)


9-Hydroxybenzo[a]pyrene, also known as benzo[Def]chrysen-9-ol or 9-hydroxybenzo(a)Pyrene, 3H-labeled, is classified as a member of the Benzopyrenes. Benzopyrenes are organic compounds containing a benzene fused to a pyrene(benzo[def]phenanthrene) ring system. 9-Hydroxybenzo[a]pyrene is considered to be practically insoluble (in water) and acidic

   

8-Hydroxybenzo[a]pyrene

8-Hydroxybenzo[a]pyrene

C20H12O (268.0888)


   

7-Hydroxybenzo(a)pyrene

7-Hydroxybenzo(a)pyrene

C20H12O (268.0888)


   

5-Hydroxybenzo(a)pyrene

5-Hydroxybenzo(a)pyrene

C20H12O (268.0888)


   

4-Hydroxybenzo[a]pyrene

4-Hydroxybenzo[a]pyrene

C20H12O (268.0888)


   

12-Hydroxybenzo[a]pyrene

12-Hydroxybenzo[a]pyrene

C20H12O (268.0888)


   

11-Hydroxybenzo[a]pyrene

11-Hydroxybenzo[a]pyrene

C20H12O (268.0888)


   

10-Hydroxybenzo[a]pyrene

10-Hydroxybenzo[a]pyrene

C20H12O (268.0888)


   

6-Hydroxybenzo[a]pyrene

6-Hydroxybenzo[a]pyrene

C20H12O (268.0888)


   

Benzo[a]pyrene-9,10-oxide

4-oxahexacyclo[11.6.2.0²,⁸.0³,⁵.0¹⁰,²⁰.0¹⁷,²¹]henicosa-1(20),2(8),6,9,11,13(21),14,16,18-nonaene

C20H12O (268.0888)


This compound belongs to the family of Pyrenes. These are compounds containing a pyrene moiety, which consists four fused benzene rings, resulting in a flat aromatic system.

   

Benzo[a]pyrene-7,8-oxide

6-oxahexacyclo[11.6.2.0²,⁸.0⁵,⁷.0¹⁰,²⁰.0¹⁷,²¹]henicosa-1,3,8,10(20),11,13(21),14,16,18-nonaene

C20H12O (268.0888)


This compound belongs to the family of Pyrenes. These are compounds containing a pyrene moiety, which consists four fused benzene rings, resulting in a flat aromatic system.

   

Benzo[a]pyrene-4,5-oxide

18-oxahexacyclo[10.7.2.0³,⁸.0⁹,²⁰.0¹⁶,²¹.0¹⁷,¹⁹]henicosa-1,3,5,7,9(20),10,12(21),13,15-nonaene

C20H12O (268.0888)


This compound belongs to the family of Chrysenes. These are compounds containing the polyaromatic chrysene moiety, which consists of a benzene ring fused to a phenanthrene ring system to form Benzo[a]phenanthrene. D009676 - Noxae > D002273 - Carcinogens

   

UNII-YJP146PXQT

1-(6-Hydroxy-2-(4-hydroxyphenyl)-1-benzofuran-3-yl)ethanone

C16H12O4 (268.0736)


   

6-Hydroxy-2-methoxyflavone

6-Hydroxy-2-(2-methoxyphenyl)-4H-1-benzopyran-4-one

C16H12O4 (268.0736)


   

2,3-Dihydroxycarbamazepine

5,6-dihydroxy-2-azatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,9,11,13-heptaene-2-carboxamide

C15H12N2O3 (268.0848)


2,3-Dihydroxycarbamazepine is a metabolite of carbamazepine. Carbamazepine (CBZ) is an anticonvulsant and mood-stabilizing drug used primarily in the treatment of epilepsy and bipolar disorder, as well as trigeminal neuralgia. (Wikipedia)

   

Benzo[a]pyrene-11,12-epoxide

Benzo[a]pyrene-11,12-epoxide

C20H12O (268.0888)


   

Deoxynonulosonate

Keto-Deoxy-Nonulonic acid

C9H16O9 (268.0794)


   

DL-Homocystine

4,4-Dithiobis[2-aminobutyric Acid]

C8H16N2O4S2 (268.0551)


4,4'-Disulfanediylbis(2-aminobutanoic acid) is an endogenous metabolite. DL-Homocystine is the double-bonded form of homocysteine and homocysteine is recognized as an important substance in the pathogenesis and pathophysiology of schizophrenia.

   

2-O-(alpha-D-glucopyranosyl)-D-glyceric acid

2-O-(alpha-D-glucopyranosyl)-D-glyceric acid

C9H16O9 (268.0794)


   

5-Hydroxy-7-methoxyisoflavone

5-Hydroxy-7-methoxyisoflavone

C16H12O4 (268.0736)


   

8-Hydroxy-1-methoxy-3-methylanthraquinone

8-hydroxy-1-methoxy-3-methyl-9,10-dihydroanthracene-9,10-dione

C16H12O4 (268.0736)


8-Hydroxy-1-methoxy-3-methylanthraquinone is found in garden rhubarb. 8-Hydroxy-1-methoxy-3-methylanthraquinone is a constituent of Rumex acetosa (sorrel). Constituent of Rumex acetosa (sorrel). 8-Hydroxy-1-methoxy-3-methylanthraquinone is found in green vegetables and garden rhubarb.

   

4-Hydroxyphenytoin

2,4-Imidazolidinedione,5-(4-hydroxyphenyl)-5-phenyl-

C15H12N2O3 (268.0848)


4-Hydroxyphenytoin, also known as hydroxyphenytoin or 4-HPPH, belongs to the class of organic compounds known as phenylhydantoins. These are heterocyclic aromatic compounds containing an imiazolidinedione moiety substituted by a phenyl group. 4-Hydroxyphenytoin is a metabolite of the anti-seizure medication phenytoin (PHT) and is excreted in the urine (PMID: 15855726).

   

Trigraecum

7-hydroxy-6-methoxy-2-phenyl-4H-chromen-4-one

C16H12O4 (268.0736)


Trigraecum is found in herbs and spices. Trigraecum is isolated from Trigonella foenum-graecum (fenugreek

   

1,3-Dimethoxyanthraquinone

1,3-dimethoxy-9,10-dihydroanthracene-9,10-dione

C16H12O4 (268.0736)


1,3-Dimethoxyanthraquinone is found in beverages. 1,3-Dimethoxyanthraquinone is isolated from Asperula odorata (sweet woodruff). Isolated from Asperula odorata (sweet woodruff). 1,3-Dimethoxyanthraquinone is found in tea, herbs and spices, and beverages.

   

3-(3-hydroxyphenyl)-7-methoxy-4H-chromen-4-one

3-(3-hydroxyphenyl)-7-methoxy-4H-chromen-4-one

C16H12O4 (268.0736)


   

7-Hydroxy-5-methoxy-2-phenyl-chromen-4-one

7-Hydroxy-5-methoxy-2-phenyl-chromen-4-one

C16H12O4 (268.0736)


   

Cysteinyl-Phenylalanine

2-[(2-Amino-1-hydroxy-3-sulphanylpropylidene)amino]-3-phenylpropanoic acid

C12H16N2O3S (268.0882)


Cysteinyl-Phenylalanine is a dipeptide composed of cysteine and phenylalanine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

5-Hydroxy-6-methoxyflavone

5-Hydroxy-6-methoxyflavone

C16H12O4 (268.0736)


   

Phenylalanylcysteine

(2R)-2-[(2S)-2-amino-3-phenylpropanamido]-3-sulfanylpropanoic acid

C12H16N2O3S (268.0882)


Phenylalanylcysteine is a dipeptide composed of phenylalanine and cysteine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

3-Deoxy-D-glycero-D-galacto-2-nonulosonic acid

(4S,5R,6R,7R,8S)-4,5,6,7,8,9-hexahydroxy-2-oxononanoic acid

C9H16O9 (268.0794)


3-Deoxy-D-glycero-D-galacto-2-nonulosonic acid (KDN) is a sialic acid (Sia) that is ubiquitously expressed in vertebrates during normal development and tumorigenesis. Its expression is thought to be regulated by multiple biosynthetic steps catalyzed by several enzymes, including CMP-Sia synthetase. (PMID 11479279) Sialic acids are frequently the terminal sugars on secreted and cell surface glycoproteins and glycolipids, and their presence can have considerable influence on the biological properties of a cell. For example, the temporal appearance and disappearance of polysialic polymers has been intimately linked with the proper development of neural tissues during embryogenesis. In pathogenic diseases, including meningitis and gastric inflammation, particular microbes recognize cell surface sialic acids when invading host cells. Sialic acid residues can also mask recognition sites such as galactose residues on glycoproteins to prevent their in vivo removal by asialoglycoprotein receptors. In certain cancers, changes in sialic acid amounts, types, and linkages have been associated with tumorogenesis and cancer metastasis. (PMID 10749855) [HMDB] 3-Deoxy-D-glycero-D-galacto-2-nonulosonic acid (KDN) is a sialic acid (Sia) that is ubiquitously expressed in vertebrates during normal development and tumorigenesis. Its expression is thought to be regulated by multiple biosynthetic steps catalyzed by several enzymes, including CMP-Sia synthetase. (PMID 11479279) Sialic acids are frequently the terminal sugars on secreted and cell surface glycoproteins and glycolipids, and their presence can have considerable influence on the biological properties of a cell. For example, the temporal appearance and disappearance of polysialic polymers has been intimately linked with the proper development of neural tissues during embryogenesis. In pathogenic diseases, including meningitis and gastric inflammation, particular microbes recognize cell surface sialic acids when invading host cells. Sialic acid residues can also mask recognition sites such as galactose residues on glycoproteins to prevent their in vivo removal by asialoglycoprotein receptors. In certain cancers, changes in sialic acid amounts, types, and linkages have been associated with tumorogenesis and cancer metastasis. (PMID 10749855).

   

Allopurinol riboside

1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H,4H,7H-pyrazolo[3,4-d]pyrimidin-4-one

C10H12N4O5 (268.0808)


Allopurinol is an analog of the natural purines in the body, and is quickly metabolized to oxypurines which is also a xanthine oxidase inhibitor. Allopurinol is a white, powdery drug used to treat gout. Its use in the United States was started in 1964. It is an isomer of hypoxanthine and inhibits the production of uric acid, the metabolite responsible for gout, by inhibiting the enzyme xanthine oxidase. The side effects of high levels of precursors are usually minor. A small percentage of people develop a rash and must discontinue this drug. The most serious adverse event is a hypersensitivity syndrome consisting of fever, skin rash, eosinophilia, hepatitis, and worsening renal function. In some cases, allopurinol hypersensitivity syndrome. [HMDB] Allopurinol is an analog of the natural purines in the body, and is quickly metabolized to oxypurines which is also a xanthine oxidase inhibitor. Allopurinol is a white, powdery drug used to treat gout. Its use in the United States was started in 1964. It is an isomer of hypoxanthine and inhibits the production of uric acid, the metabolite responsible for gout, by inhibiting the enzyme xanthine oxidase. The side effects of high levels of precursors are usually minor. A small percentage of people develop a rash and must discontinue this drug. The most serious adverse event is a hypersensitivity syndrome consisting of fever, skin rash, eosinophilia, hepatitis, and worsening renal function. In some cases, allopurinol hypersensitivity syndrome. Allopurinol riboside, a metabolite of allopurinol, shows potent activities against parasites. Allopurinol riboside, a metabolite of allopurinol, shows potent activities against parasites.

   

L-Homocystine

2-Amino-4-{[(3S)-3-amino-3-carboxypropyl]disulphanyl}butanoic acid

C8H16N2O4S2 (268.0551)


Homocystine is the oxidized form of homocysteine. Homocystine is a dipeptide consisting of two homocysteine molecules joined by a disulfide bond. Homocysteine is a sulfur-containing amino acid that arises during methionine metabolism. Homocystine occurs only transiently before being reduced to homocysteine and converted to the harmless cystathionine via a vitamin B6-dependent enzyme. Homocystine and homocysteine-cysteine mixed disulfides account for >98\\\% of total homocysteine in plasma from healthy individuals (PMID 11592966). Homocystine has been shown to stereospecifically induce endothelial nitric oxide synthase-dependent lipid peroxidation in endothelial cells, thereby inducing a vascular cell type-specific oxidative stress. This vascular stress is associated with atherothrombotic cardiovascular disease (PMID: 14980706). High levels of homocysteine (and homocysteine) can be found in individuals suffering from homocystinura due to cystathionine synthase deficiency (PMID: 4685596) Homocystine is the double-bonded form of homocysteine, but it occurs only transiently before being converted to the harmless cystathionine via a vitamin B6-dependent enzyme. L-Homocystine is the oxidized member of the L-homocysteine. Homocysteine is a pro-thrombotic factor, vasodilation impairing agent, pro-inflammatory factor and endoplasmatic reticulum-stress inducer used to study cardiovascular disease mechanisms.

   

Homolanthionine

2-Amino-4-(3-amino-3-carboxypropanesulphonyl)butanoic acid

C8H16N2O6S (268.0729)


Homolanthionine is formed from homocysteine and homoserine by a condensation analogous to that normally leading to cystathionine. The only other known occurrence of homolanthionine in nature is in a methionine-requiring mutant strain of Escherichia coli. Patients with homocystinuria excrete small amounts of L-homolanthionine in their urine. [HMDB] Homolanthionine is formed from homocysteine and homoserine by a condensation analogous to that normally leading to cystathionine. The only other known occurrence of homolanthionine in nature is in a methionine-requiring mutant strain of Escherichia coli. Patients with homocystinuria excrete small amounts of L-homolanthionine in their urine.

   

Arabinosylhypoxanthine

9-[(3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-3H-purin-6-one

C10H12N4O5 (268.0808)


Arabinosylhypoxanthine is found to have a potent antiviral activity for herpes simplex infected cells. The final metabolite in the conversion of Arabinosyladenine-5-monophosphate to arabinosyladenine then to Arabinosylhypoxanthine. Found to have a potent antiviral activity for herpes simplex infected cells. The final metabolite in the conversion of Arabinosyladenine-5-monophosphate to arabinosyladenine then to Arabinosylhypoxanthine. [HMDB] Arabinosylhypoxanthine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

   

DHAP(6:0)

[3-(hexanoyloxy)-2-oxopropoxy]phosphonic acid

C9H17O7P (268.0712)


DHAP(6:0) is the hexanoyl derivative of Dihydroxyacetone phosphate. It is also known as an alkyl-DHAP. This compound is formed by hexanoic acid reacting with DHAP. Alkyl-DHAPs are intermediates in the synthesis of ether phospholipids. The initial steps of ether phospholipid biosynthesis take place in peroxisomes. Alkyl-dihydroxyacetonephosphate synthase is the peroxisomal enzyme that actually introduces the ether linkage. Levels of Alkyl-DHAP have been found to be strongly reduced in human fibroblasts derived from Zellweger syndrome and rhizomelic chondrodysplasia punctata patients. Four other enzymes are known to be involved in the metabolism of acyl-DHAP and alkyl-DHAP. These include: acyl-DHAP/alkyl-DHAP oxidoreductase, DHAP acyltransferase, alkyl-DHAP phosphohydrolase, and a dinitrofluorobenzene-insensitive acyl-DHAP acylhydrolase. Dihydroxyacetone phosphate (DHAP) is a biochemical compound primarily involved in the glycolysis metabolic pathway. DHAP is also the product of the dehydrogenation of L-glycerol-3-phosphate which is part of the entry of glycerol (sourced from triglycerides) into the glycolytic pathway. Conversely, reduction of glycolysis-derived DHAP to L-glycerol-3-phosphate provides adipose cells with the activated glycerol backbone they require to synthesize new triglycerides. Both reactions are catalyzed by the enzyme glycerol 3-phosphate dehydrogenase with NAD+/NADH as cofactor. DHAP may be referred to as glycerone phosphate in older texts. [HMDB] DHAP(6:0) is the hexanoyl derivative of Dihydroxyacetone phosphate. It is also known as an alkyl-DHAP. This compound is formed by hexanoic acid reacting with DHAP. Alkyl-DHAPs are intermediates in the synthesis of ether phospholipids. The initial steps of ether phospholipid biosynthesis take place in peroxisomes. Alkyl-dihydroxyacetonephosphate synthase is the peroxisomal enzyme that actually introduces the ether linkage. Levels of Alkyl-DHAP have been found to be strongly reduced in human fibroblasts derived from Zellweger syndrome and rhizomelic chondrodysplasia punctata patients. Four other enzymes are known to be involved in the metabolism of acyl-DHAP and alkyl-DHAP. These include: acyl-DHAP/alkyl-DHAP oxidoreductase, DHAP acyltransferase, alkyl-DHAP phosphohydrolase, and a dinitrofluorobenzene-insensitive acyl-DHAP acylhydrolase. Dihydroxyacetone phosphate (DHAP) is a biochemical compound primarily involved in the glycolysis metabolic pathway. DHAP is also the product of the dehydrogenation of L-glycerol-3-phosphate which is part of the entry of glycerol (sourced from triglycerides) into the glycolytic pathway. Conversely, reduction of glycolysis-derived DHAP to L-glycerol-3-phosphate provides adipose cells with the activated glycerol backbone they require to synthesize new triglycerides. Both reactions are catalyzed by the enzyme glycerol 3-phosphate dehydrogenase with NAD+/NADH as cofactor. DHAP may be referred to as glycerone phosphate in older texts.

   

3'-HPPH

(5R)-5-(3-hydroxyphenyl)-5-phenylimidazolidine-2,4-dione

C15H12N2O3 (268.0848)


3-HPPH, also called (5R)-5-(3-hydroxyphenyl)-5-phenylimidazolidine-2,4-dione or 3’-hydroxyphenytoin, is a metabolite of Phenytoin. Phenytoin is an anticonvulsant used to treat epilepsy. 3-HPPH belongs to the family of compounds known as Diphenylmethanes. These are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups. 3-HPPH or 3’-hydroxyphenytoin is only found in individuals that have used or taken Phenytoin.

   

Phenytoin arene-oxide

5-{7-oxabicyclo[4.1.0]hepta-2,4-dien-3-yl}-5-phenylimidazolidine-2,4-dione

C15H12N2O3 (268.0848)


Phenytoin arene-oxide is a metabolite of phenytoin. Phenytoin sodium is a commonly used antiepileptic. Phenytoin acts to suppress the abnormal brain activity seen in seizure by reducing electrical conductance among brain cells by stabilizing the inactive state of voltage-gated sodium channels. Aside from seizures, it is an option in the treatment of trigeminal neuralgia in the event that carbamazepine or other first-line treatment seems inappropriate. It is sometimes considered a class 1b antiarrhythmic. (Wikipedia)

   

(1S,2R)-N-Methyl-1-oxo-2-pyridin-3-ylthiane-2-carbothioamide

N-methyl-1-oxo-2-(pyridin-3-yl)-1lambda4-thiane-2-carbothioamide

C12H16N2OS2 (268.0704)


   

8-Methylxanthen-9-one-4-acetic acid

2-(8-methyl-9-oxo-9H-xanthen-4-yl)acetic acid

C16H12O4 (268.0736)


   

5-(m-Hydroxyphenyl)-5-phenylhydantoin

5-(3-hydroxyphenyl)-5-phenylimidazolidine-2,4-dione

C15H12N2O3 (268.0848)


   

5,5-Diphenyl-2-thiohydantoin

5,5-diphenyl-2-sulfanylideneimidazolidin-4-one

C15H12N2OS (268.067)


   

Ara-HX

2-(6-hydroxy-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C10H12N4O5 (268.0808)


   

Alconil

Spiro(2-fluoro-9H-fluorene-9,4-imidazolidine)-2,5-dione

C15H9FN2O2 (268.0648)


   

Clomoxir

Sodium 2-(5-(4-chlorophenyl)pentyl)oxirane-2-carboxylate

C14H17ClO3 (268.0866)


C471 - Enzyme Inhibitor

   

Methyl 3-[(diethoxyphosphorothioyl)oxy]but-2-enoate

methyl 3-{[diethoxy(sulfanylidene)-lambda5-phosphanyl]oxy}but-2-enoate

C9H17O5PS (268.0534)


   

Dimethyl cystine

methyl 2-amino-3-[(2-amino-3-methoxy-3-oxopropyl)disulfanyl]propanoate

C8H16N2O4S2 (268.0551)


   

Disperse red 11

1,4-diamino-2-methoxy-9,10-dihydroanthracene-9,10-dione

C15H12N2O3 (268.0848)


   

Ethylenedicysteine

2-({2-[(1-carboxy-2-sulfanylethyl)amino]ethyl}amino)-3-sulfanylpropanoic acid

C8H16N2O4S2 (268.0551)


   

Formycin b

3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H,6H,7H-pyrazolo[4,3-d]pyrimidin-7-one

C10H12N4O5 (268.0808)


   

Fructose lactate

3,4,5,6-Tetrahydroxy-6-(hydroxymethyl)oxan-2-yl 2-hydroxypropanoic acid

C9H16O9 (268.0794)


   

Furobufen

4-{8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),2,4,6,9,11-hexaen-4-yl}-4-oxobutanoic acid

C16H12O4 (268.0736)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   

galactose lactate

2,3,4,5-tetrahydroxy-6-(hydroxymethyl)oxan-2-yl 2-hydroxypropanoate

C9H16O9 (268.0794)


   

hydroxyphenylphenylhydantoin

5-hydroxy-1,3-diphenylimidazolidine-2,4-dione

C15H12N2O3 (268.0848)


   

Pyran-3,4-dicarboxylic anhydride, tetrahydro-2-methyl-6-(tetrahydro-2,5-dioxo-3-furyl)-, polymer

Pyran-3,4-dicarboxylic anhydride, tetrahydro-2-methyl-6-(tetrahydro-2,5-dioxo-3-furyl)-, polymer

C12H12O7 (268.0583)


   

p-Hydroxy-p-methylphenytoin

3-hydroxy-5,5-diphenylimidazolidine-2,4-dione

C15H12N2O3 (268.0848)


   

p-Hydroxyphenyl-phenylhydantoin

1-(4-hydroxyphenyl)-3-phenylimidazolidine-2,4-dione

C15H12N2O3 (268.0848)


   

Penicillamine cysteine disulfide

2-Amino-3-[(2-amino-2-carboxyethyl)disulphanyl]-3-methylbutanoic acid

C8H16N2O4S2 (268.0551)


   

Phospho-ibuprofen

2-(4-Isobutylphenyl)propionic acid 4-(diethoxyphosphoryloxy)butyl ester

C13H17O4P (268.0864)


   

zardaverine

6-[4-(difluoromethoxy)-3-methoxyphenyl]-2,3-dihydropyridazin-3-one

C12H10F2N2O3 (268.0659)


D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor

   

(-)-medicarpin

14-methoxy-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-2,4,6,9,11,13,15-heptaen-5-ol

C16H12O4 (268.0736)


(-)-medicarpin is a member of the class of compounds known as isoflavonoids. Isoflavonoids are natural products derived from 3-phenylchromen-4-one (-)-medicarpin is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). (-)-medicarpin can be found in a number of food items such as oriental wheat, arrowroot, french plantain, and grape, which makes (-)-medicarpin a potential biomarker for the consumption of these food products.

   

Cedazuridine

(4R)-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1,3-diazinan-2-one

C9H14F2N2O5 (268.0871)


   

Inosine

Inosine

C10H12N4O5 (268.0808)


G - Genito urinary system and sex hormones > G01 - Gynecological antiinfectives and antiseptics > G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06B - Chemotherapeutics for topical use > D06BB - Antivirals COVID info from COVID-19 Disease Map, clinicaltrial, clinicaltrials, clinical trial, clinical trials S - Sensory organs > S01 - Ophthalmologicals Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Inosine is an endogenous purine nucleoside produced by catabolism of adenosine. Inosine has anti-inflammatory, antinociceptive, immunomodulatory and neuroprotective effects. Inosine is an agonist for adenosine A1 (A1R) and A2A (A2AR) receptors[1][2][3]. Inosine is an endogenous purine nucleoside produced by catabolism of adenosine. Inosine has anti-inflammatory, antinociceptive, immunomodulatory and neuroprotective effects. Inosine is an agonist for adenosine A1 (A1R) and A2A (A2AR) receptors[1][2][3]. Inosine is an endogenous purine nucleoside produced by catabolism of adenosine. Inosine has anti-inflammatory, antinociceptive, immunomodulatory and neuroprotective effects. Inosine is an agonist for adenosine A1 (A1R) and A2A (A2AR) receptors[1][2][3]. Inosine is an endogenous purine nucleoside produced by catabolism of adenosine. Inosine has anti-inflammatory, antinociceptive, immunomodulatory and neuroprotective effects. Inosine is an agonist for adenosine A1 (A1R) and A2A (A2AR) receptors[1][2][3].

   

Techtochrysin

5-Hydroxy-7-methylflavone; 7-O-Methylchrysin; Tectochrysine

C16H12O4 (268.0736)


Tectochrysin is a monohydroxyflavone that is flavone substituted by a hydroxy group at position 4 and a methoxy group at position 7 respectively. It has a role as a plant metabolite, an antidiarrhoeal drug and an antineoplastic agent. It is a monohydroxyflavone and a monomethoxyflavone. It is functionally related to a flavone. Tectochrysin is a natural product found in Hedychium spicatum, Populus laurifolia, and other organisms with data available. A monohydroxyflavone that is flavone substituted by a hydroxy group at position 4 and a methoxy group at position 7 respectively. Tectochrysin (Techtochrysin) is one of the major flavonoids of Alpinia oxyphylla Miquel. Tectochrysin inhibits activity of NF-κB. Tectochrysin (Techtochrysin) is one of the major flavonoids of Alpinia oxyphylla Miquel. Tectochrysin inhibits activity of NF-κB.

   

Pratol

4H-1-Benzopyran-4-one, 7-hydroxy-2-(4-methoxyphenyl)-

C16H12O4 (268.0736)


   

Lespedezol A1

9-Hydroxyfurano[23:3,2]pterocarpene

C16H12O4 (268.0736)


   

ANEMARCOUMARIN A

ANEMARCOUMARIN A

C16H12O4 (268.0736)


   
   

Rubiadin 1-methyl ether

Rubiadin-1-methyl ether

C16H12O4 (268.0736)


Rubiadin-1-methyl ether is a natural anthraquinone isolated from Morinda officinalis How, and inhibits osteoclastic bone resorption via inhibition on the phosphorylation of NF-κB p65 and the degradation of IκBα as well as decrease in the nuclear translocation of p65[1]. Rubiadin-1-methyl ether is a natural anthraquinone isolated from Morinda officinalis How, and inhibits osteoclastic bone resorption via inhibition on the phosphorylation of NF-κB p65 and the degradation of IκBα as well as decrease in the nuclear translocation of p65[1].

   
   

Rubiawallin B

Rubiawallin B

C16H12O4 (268.0736)


   

Cirrhopetalin

7-hydroxy-4-methoxy-2,3-methylenedioxyphenanthrene

C16H12O4 (268.0736)


   

7-Hydroxy-8-methoxy-2-methylanthraquinone

7-Hydroxy-8-methoxy-2-methylanthraquinone

C16H12O4 (268.0736)


   

DC 86Y

Saphenic acid

C15H12N2O3 (268.0848)


   

Strobochrysin

5,7-Dihydroxy-6-methyl-2-phenyl-4H-1-benzopyran-4-one

C16H12O4 (268.0736)


   

5-Hydroxy-6-methoxyflavone

5-Hydroxy-6-methoxyflavone

C16H12O4 (268.0736)


   

5-hydroxy-2-methoxyflavone

5-hydroxy-2-methoxyflavone

C16H12O4 (268.0736)


   

6-Hydroxy-4-methoxyflavone

6-Hydroxy-4-methoxyflavone

C16H12O4 (268.0736)


   

Isopratol

4-Hydroxy-7-methoxyflavone

C16H12O4 (268.0736)


   

4-Methoxyflavonol

3-Hydroxy-4-methoxyflavone

C16H12O4 (268.0736)


relative retention time with respect to 9-anthracene Carboxylic Acid is 1.247 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.249

   

5-Hydroxy-7-methoxyisoflavone

5-Hydroxy-7-methoxyisoflavone

C16H12O4 (268.0736)


   

Pallidiflorin

5-Hydroxy-4-methoxyisoflavone

C16H12O4 (268.0736)


   

Isodalbergin

7-Hydroxy-6-methoxy-4-phenylcoumarin

C16H12O4 (268.0736)


   

Dalbergin

2H-1-Benzopyran-2-one, 6-hydroxy-7-methoxy-4-phenyl-

C16H12O4 (268.0736)


Dalbergin is a neoflavonoid. Dalbergin is a natural product found in Dalbergia cochinchinensis, Pterocarpus santalinus, and other organisms with data available.

   

Biochanin B

4H-1-Benzopyran-4-one, 7-hydroxy-3-(4-methoxyphenyl)- (9CI)

C16H12O4 (268.0736)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D004967 - Estrogens Formononetin is a potent FGFR2 inhibitor with an IC50 of ~4.31 μM. Formononetin potently inhibits angiogenesis and tumor growth[1]. Formononetin is a potent FGFR2 inhibitor with an IC50 of ~4.31 μM. Formononetin potently inhibits angiogenesis and tumor growth[1].

   

Trigraecum

7-Hydroxy-6-methoxyflavone

C16H12O4 (268.0736)


   

Isoformononetin

4H-1-Benzopyran-4-one, 3-(4-hydroxyphenyl)-7-methoxy-

C16H12O4 (268.0736)


Isoformononetin is an analog of Daidzein (HY-N0019) and has immunoprotective effects. Isoformononetin inhibits the differentiation of Th17 and B-cells lymphopoesis to promote osteogenesis in estrogen-deficient bone loss conditions[1]. Isoformononetin is an analog of Daidzein (HY-N0019) and has immunoprotective effects. Isoformononetin inhibits the differentiation of Th17 and B-cells lymphopoesis to promote osteogenesis in estrogen-deficient bone loss conditions[1].

   

N-(3-Cyano-4,5-dihydronaphtho[1,2-b]thiophen-2-yl)acetamide

N-(3-Cyano-4,5-dihydronaphtho[1,2-b]thiophen-2-yl)acetamide

C15H12N2OS (268.067)


   

1,4-Dimethoxyanthraquinone

1,4-Dimethoxyanthraquinone

C16H12O4 (268.0736)


   

zardaverine

zardaverine

C12H10F2N2O3 (268.0659)


D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor

   

3-Methoxyflavonol

3-HYDROXY-3-METHOXYFLAVONE

C16H12O4 (268.0736)


relative retention time with respect to 9-anthracene Carboxylic Acid is 1.241 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.240 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.247 3'-Methoxyflavonol is a selective agonist of neuromedin U 2 receptor (NMU2R).

   

7-HYDROXY-3-METHOXYFLAVONE

7-HYDROXY-3-METHOXYFLAVONE

C16H12O4 (268.0736)


relative retention time with respect to 9-anthracene Carboxylic Acid is 1.167 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.168 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.162 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.164

   

5-HYDROXY-3-METHOXYFLAVONE

5-HYDROXY-3-METHOXYFLAVONE

C16H12O4 (268.0736)


relative retention time with respect to 9-anthracene Carboxylic Acid is 1.313 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.314

   

7-HYDROXY-2-METHOXYFLAVONE

7-HYDROXY-2-METHOXYFLAVONE

C16H12O4 (268.0736)


   

7-hydroxy-3-(4-methoxyphenyl)-2H-chromen-2-one

7-hydroxy-3-(4-methoxyphenyl)-2H-chromen-2-one

C16H12O4 (268.0736)


   

MEGxp0_001760

MEGxp0_001760

C16H12O4 (268.0736)


   

6-methoxyflavonol

3-Hydroxy-6-methoxyflavone

C16H12O4 (268.0736)


   

7-Methoxyflavonol

4H-1-Benzopyran-4-one,3-hydroxy-7-methoxy-2-phenyl-

C16H12O4 (268.0736)


   
   

Methyl 2-methoxyphenazine-1-carboxylate

Methyl 2-methoxyphenazine-1-carboxylate

C15H12N2O3 (268.0848)


   

SCHEMBL16227229

SCHEMBL16227229

C16H12O4 (268.0736)


   

5,7-Dihydroxy-8-methylflavone

5,7-Dihydroxy-8-methylflavone

C16H12O4 (268.0736)


   

1-Hydroxy-5-methoxy-2-methylanthracene-9,10-dione

1-Hydroxy-5-methoxy-2-methylanthracene-9,10-dione

C16H12O4 (268.0736)


   

1-Oxo-5-Hydroxy-6-methoxy-2-methyl-3-phenylbenzofuran

1-Oxo-5-Hydroxy-6-methoxy-2-methyl-3-phenylbenzofuran

C16H12O4 (268.0736)


   

1,8-Dimethoxyanthraquinone

1,8-Dimethoxyanthraquinone

C16H12O4 (268.0736)


   

2,7-Dimethylchrysazin

2,7-Dimethylchrysazin

C16H12O4 (268.0736)


   
   

DTXSID70805928

DTXSID70805928

C16H12O4 (268.0736)


   

4-Hydroxy-3-Methoxyflavone

4-Hydroxy-3-Methoxyflavone

C16H12O4 (268.0736)


   

228574-06-9

228574-06-9

C16H12O4 (268.0736)


   

1-hydroxy-6-methoxy-8-methyl-anthraquinone

1-hydroxy-6-methoxy-8-methyl-anthraquinone

C16H12O4 (268.0736)


   

6H-Benzofuro[3,2-c][1]benzopyran-9-ol, 6a,11a-dihydro-3-methoxy-, (6aR-cis)-; (6aR,11aR)-6a,11a-Dihydro-3-methoxy-6H-benzofuro[3,2-c][1]benzopyran-9-ol; 3-Methoxy-9-hydroxypterocarpan

6H-Benzofuro[3,2-c][1]benzopyran-9-ol, 6a,11a-dihydro-3-methoxy-, (6aR-cis)-; (6aR,11aR)-6a,11a-Dihydro-3-methoxy-6H-benzofuro[3,2-c][1]benzopyran-9-ol; 3-Methoxy-9-hydroxypterocarpan

C16H12O4 (268.0736)


   

2,3-Dimethoxyanthracene-9,10-dione

2,3-Dimethoxyanthracene-9,10-dione

C16H12O4 (268.0736)


   

SCHEMBL11921338

SCHEMBL11921338

C16H12O4 (268.0736)


   

1-Hydroxy-6-methoxy-3-methylanthrachinon|6-Me ether-Phomarin|phomarin 6-methyl ether|Phomarin-6-methylether

1-Hydroxy-6-methoxy-3-methylanthrachinon|6-Me ether-Phomarin|phomarin 6-methyl ether|Phomarin-6-methylether

C16H12O4 (268.0736)


   

7-Hydroxy-3-(4-hydroxybenzylidene)chroman-4-one

7-Hydroxy-3-(4-hydroxybenzylidene)chroman-4-one

C16H12O4 (268.0736)


   

CHEMBL298539

CHEMBL298539

C16H12O4 (268.0736)


   

4-Methoxy-1-phenazinecarboxylic acid methyl ester

4-Methoxy-1-phenazinecarboxylic acid methyl ester

C15H12N2O3 (268.0848)


   

1-Hydroxy-3-methoxy-6-methylanthraquinone

1-Hydroxy-3-methoxy-6-methylanthraquinone

C16H12O4 (268.0736)


   

1-hydroxy-5-methoxy-3-methyl-9,10 dihydroanthracene 9,10-dione|1-Hydroxy-5-methoxy-3-methyl-anthrachinon|1-hydroxy-5-methoxy-3-methyl-anthraquinone|ziganein-5-methyl ether

1-hydroxy-5-methoxy-3-methyl-9,10 dihydroanthracene 9,10-dione|1-Hydroxy-5-methoxy-3-methyl-anthrachinon|1-hydroxy-5-methoxy-3-methyl-anthraquinone|ziganein-5-methyl ether

C16H12O4 (268.0736)


   

rosellisin aldehyde

rosellisin aldehyde

C12H12O7 (268.0583)


   

SCHEMBL824463

SCHEMBL824463

C16H12O4 (268.0736)


   

Isooxoflavidinin

Isooxoflavidinin

C16H12O4 (268.0736)


   
   

SCHEMBL16932394

SCHEMBL16932394

C16H12O4 (268.0736)


   

4-hydroxy-5-methoxycanthin-6-one

4-hydroxy-5-methoxycanthin-6-one

C15H12N2O3 (268.0848)


   

Digitolutein

2-hydroxy-1-methoxy-3-methyl-anthracene-9,10-dione;4-Ethylcyclohexanone

C16H12O4 (268.0736)


Digitolutein is a natural product found in Digitalis isabelliana, Digitalis viridiflora, and other organisms with data available.

   

SCHEMBL5807605

SCHEMBL5807605

C12H12O7 (268.0583)


   

1-Hydroxy-8-methoxy-3-methylanthracene-9,10-dione

1-Hydroxy-8-methoxy-3-methylanthracene-9,10-dione

C16H12O4 (268.0736)


   

9-methoxy-6-methylphenazine-1-carboxylic acid

9-methoxy-6-methylphenazine-1-carboxylic acid

C15H12N2O3 (268.0848)


   

1-Hydroxy-2-methyl-6-methoxyanthraquinone

1-Hydroxy-2-methyl-6-methoxyanthraquinone

C16H12O4 (268.0736)


   

Hallachrome

Hallachrome

C16H12O4 (268.0736)


   

6-(3,4-dihydroxyphenyl)naphthalene-2,3-diol

6-(3,4-dihydroxyphenyl)naphthalene-2,3-diol

C16H12O4 (268.0736)


   

1-Acetyl-3-methoxycarbonyl-beta-carboline

1-Acetyl-3-methoxycarbonyl-beta-carboline

C15H12N2O3 (268.0848)


   

(1S,5R,6R)-5,6-dihydroxy-3-(hydroxymethyl)-2-oxocyclohex-3-en-1-yl furan-2-carboxylate|epoxydine B

(1S,5R,6R)-5,6-dihydroxy-3-(hydroxymethyl)-2-oxocyclohex-3-en-1-yl furan-2-carboxylate|epoxydine B

C12H12O7 (268.0583)


   
   

1-hydroxy-7-methoxy-3-methylanthraquinone

1-hydroxy-7-methoxy-3-methylanthraquinone

C16H12O4 (268.0736)


   

1,2-dimethoxyanthracene-9,10-dione

1,2-dimethoxyanthracene-9,10-dione

C16H12O4 (268.0736)


   

2-(1H-Pyrrole-2-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid methyl ester

2-(1H-Pyrrole-2-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid methyl ester

C15H12N2O3 (268.0848)


   
   

1-hydroxy-2-methoxy-6-methyl-anthracene-9,10-dione

1-hydroxy-2-methoxy-6-methyl-anthracene-9,10-dione

C16H12O4 (268.0736)


   

5-hydroxy-8-methoxyflavone

5-hydroxy-8-methoxyflavone

C16H12O4 (268.0736)


   

SCHEMBL12304029

SCHEMBL12304029

C16H12O4 (268.0736)


   

3-(4-hydroxy-phenyl)-7-methoxy-chromen-2-one|3-(p-hydroxyphenyl)-7-methoxycoumarin|7-Methoxy-4-hydroxy-3-phenylcoumarin

3-(4-hydroxy-phenyl)-7-methoxy-chromen-2-one|3-(p-hydroxyphenyl)-7-methoxycoumarin|7-Methoxy-4-hydroxy-3-phenylcoumarin

C16H12O4 (268.0736)


   

5-Acetyl-5,10-dihydrophenazine-1-carboxylic acid

5-Acetyl-5,10-dihydrophenazine-1-carboxylic acid

C15H12N2O3 (268.0848)


   

6-hydroxy-8-methoxy-3-methyl-1,8-anthraquinone

6-hydroxy-8-methoxy-3-methyl-1,8-anthraquinone

C16H12O4 (268.0736)


   

(-)-Medicarpin

(-)-Medicarpin

C16H12O4 (268.0736)


   

3,6-Anhydro-D-galactose-diaethyldithioacetal|3,6-Anhydro-D-galactose-diethyl-mercaptal|3,6-anhydro-D-galactose-diethyldithioacetal|3,6-Anhydro-D-galaktose-diethylmercaptal|3,6-anhydro-L-galactose diethyl dithioacetal

3,6-Anhydro-D-galactose-diaethyldithioacetal|3,6-Anhydro-D-galactose-diethyl-mercaptal|3,6-anhydro-D-galactose-diethyldithioacetal|3,6-Anhydro-D-galaktose-diethylmercaptal|3,6-anhydro-L-galactose diethyl dithioacetal

C10H20O4S2 (268.0803)


   

Oxoflavidinin

Oxoflavidinin

C16H12O4 (268.0736)


   

6-HYDROXY-7-METHOXYFLAVONE

6-HYDROXY-7-METHOXYFLAVONE

C16H12O4 (268.0736)


   

DTXSID50631686

DTXSID50631686

C16H12O4 (268.0736)


   

8-hydroxy-9-methoxycanthin-6-one

8-hydroxy-9-methoxycanthin-6-one

C15H12N2O3 (268.0848)


   

Swerilactone E

Swerilactone E

C16H12O4 (268.0736)


   
   
   

2-hydroxy-7-methoxyflavone

2-hydroxy-7-methoxyflavone

C16H12O4 (268.0736)


   

Vesparion|Vesparione

Vesparion|Vesparione

C16H12O4 (268.0736)


   

2-Aethoxy-1-hydroxy-anthrachinon|2-ethoxy-1-hydroxy-anthraquinone|2-ethoxy-1-hydroxyanthracene-9,10-dione|2-ethoxy-1-hydroxyanthraquinone

2-Aethoxy-1-hydroxy-anthrachinon|2-ethoxy-1-hydroxy-anthraquinone|2-ethoxy-1-hydroxyanthracene-9,10-dione|2-ethoxy-1-hydroxyanthraquinone

C16H12O4 (268.0736)


   

MLS001173231

MLS001173231

C16H12O4 (268.0736)


   

CHEMBL125765

CHEMBL125765

C16H12O4 (268.0736)


   

tetramethoxy-phthalic acid anhydride

tetramethoxy-phthalic acid anhydride

C12H12O7 (268.0583)


   

2,6-Dimethylanthrarufin

2,6-Dimethylanthrarufin

C16H12O4 (268.0736)


   

Tanshinlactone A

Tanshinlactone A

C16H12O4 (268.0736)


   

1-Hydroxy-2-methoxy-7-methylanthraquinone

1-Hydroxy-2-methoxy-7-methylanthraquinone

C16H12O4 (268.0736)


   

6-methoxy-1-phenazinecarboxylic acid methyl ester

6-methoxy-1-phenazinecarboxylic acid methyl ester

C15H12N2O3 (268.0848)


   

6-Methoxy-5H-4-oxa-pyrene-2,7-diol

6-Methoxy-5H-4-oxa-pyrene-2,7-diol

C16H12O4 (268.0736)


   

4H-1-Benzopyran-4-one, 7-hydroxy-3-methoxy-2-phenyl-

4H-1-Benzopyran-4-one, 7-hydroxy-3-methoxy-2-phenyl-

C16H12O4 (268.0736)


   

3-HYDROXY-5-METHOXYFLAVONE

3-HYDROXY-5-METHOXYFLAVONE

C16H12O4 (268.0736)


   

1-hydroxy-9-methoxycanthin-6-one

1-hydroxy-9-methoxycanthin-6-one

C15H12N2O3 (268.0848)


   

Methylchrysin

Methylchrysin

C16H12O4 (268.0736)


   

7-hydroxy-3-(2-methoxyphenyl)-4H-chromen-4-one

7-hydroxy-3-(2-methoxyphenyl)-4H-chromen-4-one

C16H12O4 (268.0736)


   

AG-183

2-amino-4-(3,4,5-trihydroxyphenyl)-1,3-butadiene-1,1,3-tricarbonitrile

C13H8N4O3 (268.0596)


   

Stellarine C

Methyl 1-acetyl-9H-beta-carboline-3-carboxylate

C15H12N2O3 (268.0848)


1-acetyl-3-methoxycarbonyl-beta-carboline is a harmala alkaloid. It has a role as a metabolite. 1-Acetyl-3-methoxycarbonyl-beta-carboline is a natural product found in Stellaria dichotoma var. lanceolata with data available. A natural product found in Stellaria dichotoma var. lanceolata.

   

MK2IXH6AUE

9,10-Anthracenedione, 3-hydroxy-1-methoxy-2-methyl-

C16H12O4 (268.0736)


Rubiadin 1-methyl ether is a natural product found in Prismatomeris tetrandra, Coprosma areolata, and other organisms with data available. Rubiadin-1-methyl ether is a natural anthraquinone isolated from Morinda officinalis How, and inhibits osteoclastic bone resorption via inhibition on the phosphorylation of NF-κB p65 and the degradation of IκBα as well as decrease in the nuclear translocation of p65[1]. Rubiadin-1-methyl ether is a natural anthraquinone isolated from Morinda officinalis How, and inhibits osteoclastic bone resorption via inhibition on the phosphorylation of NF-κB p65 and the degradation of IκBα as well as decrease in the nuclear translocation of p65[1].

   

Isoformononetin

4H-1-Benzopyran-4-one, 3-(4-hydroxyphenyl)-7-methoxy-

C16H12O4 (268.0736)


Isoformononetin is a methoxyisoflavone that is isoflavone substituted at positions 4 and 7 by hydroxy and methoxy groups respectively. It has a role as a metabolite, a bone density conservation agent and an apoptosis inhibitor. It is a hydroxyisoflavone and a member of 7-methoxyisoflavones. It is functionally related to a daidzein. Isoformononetin is a natural product found in Oxytropis falcata, Arabidopsis thaliana, and other organisms with data available. A methoxyisoflavone that is isoflavone substituted at positions 4 and 7 by hydroxy and methoxy groups respectively. Isoformononetin is found in pulses. Isoformononetin is isolated from soybean (Glycine max) and other plants. Isolated from soybean (Glycine max) and other plants. Isoformononetin is found in soy bean and pulses. Isoformononetin is an analog of Daidzein (HY-N0019) and has immunoprotective effects. Isoformononetin inhibits the differentiation of Th17 and B-cells lymphopoesis to promote osteogenesis in estrogen-deficient bone loss conditions[1]. Isoformononetin is an analog of Daidzein (HY-N0019) and has immunoprotective effects. Isoformononetin inhibits the differentiation of Th17 and B-cells lymphopoesis to promote osteogenesis in estrogen-deficient bone loss conditions[1].

   

8-Methyl Chrysophanol

9,10-Anthracenedione, 1-hydroxy-8-methoxy-3-methyl-

C16H12O4 (268.0736)


1-Hydroxy-8-methoxy-3-methylanthracene-9,10-dione is a natural product found in Ventilago denticulata, Aloe debrana, and other organisms with data available.

   

Formononetin

Formononetin (Biochanin B)

C16H12O4 (268.0736)


Annotation level-1 D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D004967 - Estrogens relative retention time with respect to 9-anthracene Carboxylic Acid is 1.059 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.061 Formononetin is a potent FGFR2 inhibitor with an IC50 of ~4.31 μM. Formononetin potently inhibits angiogenesis and tumor growth[1]. Formononetin is a potent FGFR2 inhibitor with an IC50 of ~4.31 μM. Formononetin potently inhibits angiogenesis and tumor growth[1].

   

Inosine

9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one

C10H12N4O5 (268.0808)


G - Genito urinary system and sex hormones > G01 - Gynecological antiinfectives and antiseptics > G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06B - Chemotherapeutics for topical use > D06BB - Antivirals Formula(Parent): C10H12N4O5; Bottle Name:Inosine; PRIME Parent Name:Inosine; PRIME in-house No.:0256, Purines COVID info from COVID-19 Disease Map, clinicaltrial, clinicaltrials, clinical trial, clinical trials S - Sensory organs > S01 - Ophthalmologicals Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS MS2 deconvoluted using MS2Dec from all ion fragmentation data, MetaboLights identifier MTBLS1040; UGQMRVRMYYASKQ_STSL_0164_Inosine_2000fmol_180430_S2_LC02_MS02_125; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. MS2 deconvoluted using CorrDec from all ion fragmentation data, MetaboLights identifier MTBLS1040; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. relative retention time with respect to 9-anthracene Carboxylic Acid is 0.054 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.053 Inosine is an endogenous purine nucleoside produced by catabolism of adenosine. Inosine has anti-inflammatory, antinociceptive, immunomodulatory and neuroprotective effects. Inosine is an agonist for adenosine A1 (A1R) and A2A (A2AR) receptors[1][2][3]. Inosine is an endogenous purine nucleoside produced by catabolism of adenosine. Inosine has anti-inflammatory, antinociceptive, immunomodulatory and neuroprotective effects. Inosine is an agonist for adenosine A1 (A1R) and A2A (A2AR) receptors[1][2][3]. Inosine is an endogenous purine nucleoside produced by catabolism of adenosine. Inosine has anti-inflammatory, antinociceptive, immunomodulatory and neuroprotective effects. Inosine is an agonist for adenosine A1 (A1R) and A2A (A2AR) receptors[1][2][3]. Inosine is an endogenous purine nucleoside produced by catabolism of adenosine. Inosine has anti-inflammatory, antinociceptive, immunomodulatory and neuroprotective effects. Inosine is an agonist for adenosine A1 (A1R) and A2A (A2AR) receptors[1][2][3].

   

(5-Hydroxy-benzofuran-3-yl)-(4-methoxy-phenyl)-methanone

NCGC00160339-01!(5-Hydroxy-benzofuran-3-yl)-(4-methoxy-phenyl)-methanone

C16H12O4 (268.0736)


   

Homocystine

4,4-Dithiobis[2-aminobutyric Acid]

C8H16N2O4S2 (268.0551)


An organic disulfide obtained by oxidative dimerisation of homocysteine. 4,4'-Disulfanediylbis(2-aminobutanoic acid) is an endogenous metabolite.

   

L-Homocystine

4,4-Dithiobis[2-aminobutyric Acid]

C8H16N2O4S2 (268.0551)


A homocystine in which both chiral centres have L configuration. 4,4'-Disulfanediylbis(2-aminobutanoic acid) is an endogenous metabolite. L-Homocystine is the oxidized member of the L-homocysteine. Homocysteine is a pro-thrombotic factor, vasodilation impairing agent, pro-inflammatory factor and endoplasmatic reticulum-stress inducer used to study cardiovascular disease mechanisms.

   

7-Hydroxy-4-methoxyflavone

7-Hydroxy-4-methoxyflavone

C16H12O4 (268.0736)


   

7-Methoxy-4-hydroxyflavone

7-Methoxy-4-hydroxyflavone

C16H12O4 (268.0736)


   

7-Hydroxy-3(4-methoxyphenyl) coumarin

7-Hydroxy-3(4-methoxyphenyl) coumarin

C16H12O4 (268.0736)


   

3-hydroxy-6-methoxy-2-phenylchromen-4-one

NCGC00168876-02!3-hydroxy-6-methoxy-2-phenylchromen-4-one

C16H12O4 (268.0736)


   

7-hydroxy-3-(4-methoxyphenyl)chromen-4-one

NCGC00017269-08!7-hydroxy-3-(4-methoxyphenyl)chromen-4-one

C16H12O4 (268.0736)


   

6-hydroxy-5-methoxy-2-phenylchromen-4-one

NCGC00385667-01!6-hydroxy-5-methoxy-2-phenylchromen-4-one

C16H12O4 (268.0736)


   

C15H12N2O3_3-Isoquinolinecarboxylic acid, 1,2-dihydro-1-oxo-4-(1H-pyrrol-2-yl)-, methyl ester

NCGC00385864-01_C15H12N2O3_3-Isoquinolinecarboxylic acid, 1,2-dihydro-1-oxo-4-(1H-pyrrol-2-yl)-, methyl ester

C15H12N2O3 (268.0848)


   

formononetine

formononetine

C16H12O4 (268.0736)


   

(2E)-2-[hydroxy(phenyl)methylidene]-6-methoxy-1-benzofuran-3-one

(2E)-2-[hydroxy(phenyl)methylidene]-6-methoxy-1-benzofuran-3-one

C16H12O4 (268.0736)


   

methyl 1-oxo-4-(1H-pyrrol-2-yl)-2H-isoquinoline-3-carboxylate

methyl 1-oxo-4-(1H-pyrrol-2-yl)-2H-isoquinoline-3-carboxylate

C15H12N2O3 (268.0848)


   

DALBERGIONE

DALBERGIONE

C16H12O4 (268.0736)


   

Isoflavone base + 1O, 1MeO

Isoflavone base + 1O, 1MeO

C16H12O4 (268.0736)


Annotation level-3

   

7-hydroxy-3-(4-methoxyphenyl)chromen-4-one [IIN-based on: CCMSLIB00000847610]

NCGC00017269-08!7-hydroxy-3-(4-methoxyphenyl)chromen-4-one [IIN-based on: CCMSLIB00000847610]

C16H12O4 (268.0736)


   

7-hydroxy-3-(4-methoxyphenyl)chromen-4-one [IIN-based: Match]

NCGC00017269-08!7-hydroxy-3-(4-methoxyphenyl)chromen-4-one [IIN-based: Match]

C16H12O4 (268.0736)


   

Inosine; LC-tDDA; CE10

Inosine; LC-tDDA; CE10

C10H12N4O5 (268.0808)


   

Inosine; LC-tDDA; CE20

Inosine; LC-tDDA; CE20

C10H12N4O5 (268.0808)


   

Inosine; LC-tDDA; CE30

Inosine; LC-tDDA; CE30

C10H12N4O5 (268.0808)


   

Inosine; LC-tDDA; CE40

Inosine; LC-tDDA; CE40

C10H12N4O5 (268.0808)


   

Homocystine; LC-tDDA; CE10

Homocystine; LC-tDDA; CE10

C8H16N2O4S2 (268.0551)


   

Homocystine; LC-tDDA; CE20

Homocystine; LC-tDDA; CE20

C8H16N2O4S2 (268.0551)


   

Homocystine; LC-tDDA; CE30

Homocystine; LC-tDDA; CE30

C8H16N2O4S2 (268.0551)


   

Homocystine; LC-tDDA; CE40

Homocystine; LC-tDDA; CE40

C8H16N2O4S2 (268.0551)


   

Homocystine; AIF; CE0; MS2Dec

Homocystine; AIF; CE0; MS2Dec

C8H16N2O4S2 (268.0551)


   

Homocystine; AIF; CE10; MS2Dec

Homocystine; AIF; CE10; MS2Dec

C8H16N2O4S2 (268.0551)


   

Homocystine; AIF; CE30; MS2Dec

Homocystine; AIF; CE30; MS2Dec

C8H16N2O4S2 (268.0551)


   

Penicillamine cysteine disulfide

Penicillamine cysteine disulfide

C8H16N2O4S2 (268.0551)


   

3-Hydroxyphenytoin

3-Hydroxyphenytoin

C15H12N2O3 (268.0848)


   

5-(4-Hydroxyphenyl)-5-phenylhydantoin

2,4-Imidazolidinedione,5-(4-hydroxyphenyl)-5-phenyl-

C15H12N2O3 (268.0848)


   

2,4-Imidazolidinedione, 5-(7-oxabicyclo[4.1.0]hepta-2,4-dien-3-yl)-5-phenyl-

2,4-Imidazolidinedione, 5-(7-oxabicyclo[4.1.0]hepta-2,4-dien-3-yl)-5-phenyl-

C15H12N2O3 (268.0848)


   
   
   

Arabinosylhypoxanthine

hypoxanthine-9-beta-d-arabinofuranoside

C10H12N4O5 (268.0808)


Arabinosylhypoxanthine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

   

7-HYDROXY-2-METHOXYISOFLAVONE

7-HYDROXY-2-METHOXYISOFLAVONE

C16H12O4 (268.0736)


   

3-Hydroxy-4-methoxyflavone

3-Hydroxy-4-methoxyflavone

C16H12O4 (268.0736)


   

3-Deoxy-D-glycero-D-galacto-2-nonulosonic acid

(4S,5R,6R,7R,8R)-4,5,6,7,8,9-hexahydroxy-2-oxononanoic acid

C9H16O9 (268.0794)


   

Hexanoyl dhap

Hexanoyl dihydroxyacetone phosphate;1-caproylglycerone 3-phosphate

C9H17O7P (268.0712)


   

Homolanthionine

Homolanthionine

C8H16N2O6S (268.0729)


   

Ala-Ala-OH

(S)-2-(3-methoxy-4-nitrobenzamido)propanoic acid

C11H12N2O6 (268.0695)


   

Abu-Gly-OH

2-(3-ethoxy-4-nitrobenzamido)acetic acid

C11H12N2O6 (268.0695)


   

Gly-Abu-OH

(S)-2-(3-hydroxy-4-nitrobenzamido)pentanoic acid

C11H12N2O6 (268.0695)


   

3-HPPH

(5R)-5-(3-hydroxyphenyl)-5-phenylimidazolidine-2,4-dione

C15H12N2O3 (268.0848)


   

Cys-phe

2-(2-amino-3-phenylpropanamido)-3-sulfanylpropanoic acid

C12H16N2O3S (268.0882)


   

Phe-cys

2-(2-amino-3-sulfanylpropanamido)-3-phenylpropanoic acid

C12H16N2O3S (268.0882)


   

Allopurinol riboside

Allopurinol-1-ribonucleoside

C10H12N4O5 (268.0808)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents A nucleoside analogue that is allopurinol with a beta-D-ribofuranosyl moiety at the 1-position. Allopurinol riboside, a metabolite of allopurinol, shows potent activities against parasites. Allopurinol riboside, a metabolite of allopurinol, shows potent activities against parasites.

   

8-Hydroxy-1-methoxy-3-methylanthraquinone

8-hydroxy-1-methoxy-3-methyl-9,10-dihydroanthracene-9,10-dione

C16H12O4 (268.0736)


   

1,3-dimethoxyanthraquinone

1,3-dimethoxy-9,10-dihydroanthracene-9,10-dione

C16H12O4 (268.0736)


   

ziganein-1-methyl ether

5-Hydroxy-1-methoxy-3-methylanthracene-9,10-dione

C16H12O4 (268.0736)


   

2-MERCAPTO-3-M-TOLYL-3H-QUINAZOLIN-4-ONE

2-MERCAPTO-3-M-TOLYL-3H-QUINAZOLIN-4-ONE

C15H12N2OS (268.067)


   

2-MERCAPTO-3-O-TOLYL-3H-QUINAZOLIN-4-ONE

2-MERCAPTO-3-O-TOLYL-3H-QUINAZOLIN-4-ONE

C15H12N2OS (268.067)


   

4-(4-METHYLPHENYL)-5-PYRIDIN-4-YL-4H-1,2,4-TRIAZOLE-3-THIOL

4-(4-METHYLPHENYL)-5-PYRIDIN-4-YL-4H-1,2,4-TRIAZOLE-3-THIOL

C14H12N4S (268.0783)


   

2-(3-Methoxy-phenyl)-imidazo[1,2-a]pyridine-8-carboxylic acid

2-(3-Methoxy-phenyl)-imidazo[1,2-a]pyridine-8-carboxylic acid

C15H12N2O3 (268.0848)


   

METHYL 7-METHYL-9-OXO-9H-XANTHENE-1-CARBOXYLATE

METHYL 7-METHYL-9-OXO-9H-XANTHENE-1-CARBOXYLATE

C16H12O4 (268.0736)


   

1-bromo-8-phenyloctane

1-bromo-8-phenyloctane

C14H21Br (268.0827)


   
   

4,4-Stilbenedicarboxylic acid

4,4-Stilbenedicarboxylic acid

C16H12O4 (268.0736)


   

8-Hydroxy-7-methoxyflavone

8-hydroxy-7-methoxy-2-phenylchromen-4-one

C16H12O4 (268.0736)


   

2-pyrazin-2-yl-1-[4-(trifluoromethyl)phenyl]ethanol

2-pyrazin-2-yl-1-[4-(trifluoromethyl)phenyl]ethanol

C13H11F3N2O (268.0823)


   

Nifurdazil

2-Imidazolidinone,1-(2-hydroxyethyl)-3-[[(5-nitro-2-furanyl)methylene]amino]-

C10H12N4O5 (268.0808)


C254 - Anti-Infective Agent > C52588 - Antibacterial Agent

   

7-Hydroxy-5-methoxy-2-phenyl-chromen-4-one

7-Hydroxy-5-methoxy-2-phenyl-chromen-4-one

C16H12O4 (268.0736)


   

4(1H)-Quinazolinone,2,3-dihydro-3-(4-methylphenyl)-2-thioxo-

4(1H)-Quinazolinone,2,3-dihydro-3-(4-methylphenyl)-2-thioxo-

C15H12N2OS (268.067)


   

H-Cys(Bzl)-Gly-OH

H-Cys(Bzl)-Gly-OH

C12H16N2O3S (268.0882)


   

Formycin b

7H-Pyrazolo[4,3-d]pyrimidin-7-one, 1,4-dihydro-3-beta-D-ribofuranosyl-

C10H12N4O5 (268.0808)


D000970 - Antineoplastic Agents > D000903 - Antibiotics, Antineoplastic > D005573 - Formycins

   

7-BENZYLOXY-1H-INDAZOLE-3-CARBOXYLIC ACID

7-BENZYLOXY-1H-INDAZOLE-3-CARBOXYLIC ACID

C15H12N2O3 (268.0848)


   

Methyltris(dimethylsiloxy)silane

Methyltris(dimethylsiloxy)silane

C7H24O3Si4 (268.0802)


   

1,6-Hexanediylbis(methylcarbamic chloride)

1,6-Hexanediylbis(methylcarbamic chloride)

C10H18Cl2N2O2 (268.0745)


   

aprikalim

N-methyl-2-(pyridin-3-yl)tetrahydrothiopyran-2-carbothioamide 1-oxide

C12H16N2OS2 (268.0704)


   

Dimethyl cystinate

Dimethyl cystinate

C8H16N2O4S2 (268.0551)


   

Uracil,5,6-diacetamido-3-acetyl- (5CI)

Uracil,5,6-diacetamido-3-acetyl- (5CI)

C10H12N4O5 (268.0808)


   

5-(Benzyloxy)-1H-pyrrolo[3,2-b]pyridine-2-carboxylic acid

5-(Benzyloxy)-1H-pyrrolo[3,2-b]pyridine-2-carboxylic acid

C15H12N2O3 (268.0848)


   

6-(Benzyloxy)-1H-indazole-3-carboxylic acid

6-(Benzyloxy)-1H-indazole-3-carboxylic acid

C15H12N2O3 (268.0848)


   

2-Amino-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid hydrochloride

2-Amino-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid hydrochloride

C12H13ClN2O3 (268.0615)


   

3-(DIMETHYLAMINO)-2-(3-(TRIFLUOROMETHYL)BENZOYL)ACRYLONITRILE

3-(DIMETHYLAMINO)-2-(3-(TRIFLUOROMETHYL)BENZOYL)ACRYLONITRILE

C13H11F3N2O (268.0823)


   

8-METHOXY-2-METHYL-1-OXO-1,2-DIHYDROBENZO[B]-1,6-NAPHTHYRIDINE-4-CARBALDEHYDE

8-METHOXY-2-METHYL-1-OXO-1,2-DIHYDROBENZO[B]-1,6-NAPHTHYRIDINE-4-CARBALDEHYDE

C15H12N2O3 (268.0848)


   

1-(4-Bromophenyl)-4-ethylpiperazine

1-(4-Bromophenyl)-4-ethylpiperazine

C12H17BrN2 (268.0575)


   

Todralazine hydrochloride

Todralazine hydrochloride

C11H13ClN4O2 (268.0727)


D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Todralazine hydrochloride (Ecarazine hydrochloride) is an anti-hypertensive agent, acts as a β2AR blocker, with antioxidant and free radical scavenging activity[1].

   

1-(4-BROMO-2-FLUOROBENZYL)-1,4-DIAZEPANE

1-(4-BROMO-2-FLUOROBENZYL)-1,4-DIAZEPANE

C12H17BrN2 (268.0575)


   

3-BUTYL-2-MERCAPTO-5,6-DIMETHYL-3H-THIENO[2,3-D]PYRIMIDIN-4-ONE

3-BUTYL-2-MERCAPTO-5,6-DIMETHYL-3H-THIENO[2,3-D]PYRIMIDIN-4-ONE

C12H16N2OS2 (268.0704)


   

4-(5-AMINO-1H-1,2,4-TRIAZOL-3-YLAMINO)-N-METHYLBENZENESULFONAMIDE

4-(5-AMINO-1H-1,2,4-TRIAZOL-3-YLAMINO)-N-METHYLBENZENESULFONAMIDE

C9H12N6O2S (268.0742)


   
   

ethyl 4-(3-methoxyphenylthio)-3-oxobutanoate

ethyl 4-(3-methoxyphenylthio)-3-oxobutanoate

C13H16O4S (268.0769)


   

2-deoxyxanthosine

2-deoxyxanthosine

C10H12N4O5 (268.0808)


   

5-Ethynyl uridine

5-Ethynyl uridine

C11H12N2O6 (268.0695)


5-Ethynyluridine (5-EU) is a potent cell-permeable nucleoside can be used to label newly synthesized RNA. 5-Ethynyluridine can be used for isolation and sequencing of nascent RNA from neuronal populations in vivo. 5-Ethynyluridine can be used to identify changes in transcription in vivo in nervous system disease models[1][2]. 5-Ethynyluridine is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

   

Methyl 4-acetamido-2-methoxy-5-nitrobenzoate

Methyl 4-acetamido-2-methoxy-5-nitrobenzoate

C11H12N2O6 (268.0695)


   

2-(4-Acetoxyphenyl)benzothiophene

2-(4-Acetoxyphenyl)benzothiophene

C16H12O2S (268.0558)


   

2-amino-4-ethyl-5-oxo-4H-pyrano[3,2-c]chromene-3-carbonitrile

2-amino-4-ethyl-5-oxo-4H-pyrano[3,2-c]chromene-3-carbonitrile

C15H12N2O3 (268.0848)


   

2-(4-fluorobenzoyl)-1-benzofuran-5-carbaldehyde

2-(4-fluorobenzoyl)-1-benzofuran-5-carbaldehyde

C16H9FO3 (268.0536)


   

4-(4-Phenoxy-phenyl)-thiazol-2-ylamine

4-(4-Phenoxy-phenyl)-thiazol-2-ylamine

C15H12N2OS (268.067)


   
   

4-Benzoyl-3-hydroxyphenyl acrylate

4-Benzoyl-3-hydroxyphenyl acrylate

C16H12O4 (268.0736)


   

N-(4-(2,5-Dioxo-4-oxazolidinyl)butyl)-2,2,2-trifluoroacetamide

N-(4-(2,5-Dioxo-4-oxazolidinyl)butyl)-2,2,2-trifluoroacetamide

C9H11F3N2O4 (268.0671)


   

Ethyl 3-cyano-2-oxo-6-phenyl-1,2-dihydropyridine-4-carboxylate

Ethyl 3-cyano-2-oxo-6-phenyl-1,2-dihydropyridine-4-carboxylate

C15H12N2O3 (268.0848)


   

C-(2-FLUORO-BIPHENYL-4-YL)-METHYLAMINEHYDROCHLORIDE

C-(2-FLUORO-BIPHENYL-4-YL)-METHYLAMINEHYDROCHLORIDE

C16H12O4 (268.0736)


   

3-benzyl-2-sulfanylidene-1H-quinazolin-4-one

3-benzyl-2-sulfanylidene-1H-quinazolin-4-one

C15H12N2OS (268.067)


   

6-hydroxy-2-(3-methoxyphenyl)chromen-4-one

6-hydroxy-2-(3-methoxyphenyl)chromen-4-one

C16H12O4 (268.0736)


   

6-ACETYL-2-AMINO-4,5,6,7-TETRAHYDRO-THIENO[2,3-C]PYRIDINE-3-CARBOXYLIC ACID ETHYL ESTER

6-ACETYL-2-AMINO-4,5,6,7-TETRAHYDRO-THIENO[2,3-C]PYRIDINE-3-CARBOXYLIC ACID ETHYL ESTER

C12H16N2O3S (268.0882)


   
   

6-HYDROXY-4-METHOXYFLAVONE

6-HYDROXY-4-METHOXYFLAVONE

C16H12O4 (268.0736)


   

dimethylphenacylsulfonium tetrafluoroborate

dimethylphenacylsulfonium tetrafluoroborate

C10H13BF4OS (268.0716)


   

Trimethylsilyl Diethylphosphonoacetate

Trimethylsilyl Diethylphosphonoacetate

C9H21O5PSi (268.0896)


   

N,N-Ethylenedi-L-cysteine

N,N-Ethylenedi-L-cysteine

C8H16N2O4S2 (268.0551)


   

1,5-Dimethoxyanthraquinone

1,5-Dimethoxyanthraquinone

C16H12O4 (268.0736)


   

1-BENZYL-7-METHYL-1H-PYRIDO[2,3-D][1,3]OXAZINE-2,4-DIONE

1-BENZYL-7-METHYL-1H-PYRIDO[2,3-D][1,3]OXAZINE-2,4-DIONE

C15H12N2O3 (268.0848)


   

1-Benzyl-2-oxo-2,3-dihydro-1H-benzimidazole-5-carboxylic acid

1-Benzyl-2-oxo-2,3-dihydro-1H-benzimidazole-5-carboxylic acid

C15H12N2O3 (268.0848)


   

4-HYDROXY-6-METHOXYFLAVONE

4-HYDROXY-6-METHOXYFLAVONE

C16H12O4 (268.0736)


   

1-OXO-3-PHENYL-3,4-DIHYDRO-1H-ISOCHROMENE-4-CARBOXYLIC ACID

1-OXO-3-PHENYL-3,4-DIHYDRO-1H-ISOCHROMENE-4-CARBOXYLIC ACID

C16H12O4 (268.0736)


   

3-(2-aminoethylsulfanyl)-1-(4-fluorophenyl)pyrrolidine-2,5-dione

3-(2-aminoethylsulfanyl)-1-(4-fluorophenyl)pyrrolidine-2,5-dione

C12H13FN2O2S (268.0682)


   

3-(1,3-Benzodioxol-5-yl)-1-(4-hydroxyphenyl)-2-propen-1-one

3-(1,3-Benzodioxol-5-yl)-1-(4-hydroxyphenyl)-2-propen-1-one

C16H12O4 (268.0736)


   

2-(4-(4-CHLOROBUTANOYL)PHENYL)-2-METHYLPROPANOIC ACID

2-(4-(4-CHLOROBUTANOYL)PHENYL)-2-METHYLPROPANOIC ACID

C14H17ClO3 (268.0866)


   

4-HYDROXY-7-METHOXY-3-PHENYLCOUMARIN 9&

4-HYDROXY-7-METHOXY-3-PHENYLCOUMARIN 9&

C16H12O4 (268.0736)


   

5,5-DIPHENYL-2-THIOHYDANTOIN

5,5-DIPHENYL-2-THIOHYDANTOIN

C15H12N2OS (268.067)


   

3-(phenoxymethyl)-1-benzofuran-2-carboxylic acid

3-(phenoxymethyl)-1-benzofuran-2-carboxylic acid

C16H12O4 (268.0736)


   

4-benzyl-5-(4-pyridinyl)-4h-1,2,4-triazole-3-thiol

4-benzyl-5-(4-pyridinyl)-4h-1,2,4-triazole-3-thiol

C14H12N4S (268.0783)


   

Ethyl 6-chloro-5-ethoxy-1H-pyrrolo[2,3-b]pyridine-2-carboxylate

Ethyl 6-chloro-5-ethoxy-1H-pyrrolo[2,3-b]pyridine-2-carboxylate

C12H13ClN2O3 (268.0615)


   

1-(2-Bromoethyl)-4-phenylpiperazine

1-(2-Bromoethyl)-4-phenylpiperazine

C12H17BrN2 (268.0575)


   

3-anilino-4-phenyl-1H-1,2,4-triazole-5-thione

3-anilino-4-phenyl-1H-1,2,4-triazole-5-thione

C14H12N4S (268.0783)


   

6-mercaptopurine-2-deoxyriboside

6-mercaptopurine-2-deoxyriboside

C10H12N4O3S (268.063)


   

Butanoic acid,4,4-dithiobis[2-amino-, (2R,2R)-

Butanoic acid,4,4-dithiobis[2-amino-, (2R,2R)-

C8H16N2O4S2 (268.0551)


   

5-Bromo-N-cyclohexyl-N-methylpyridin-2-amine

5-Bromo-N-cyclohexyl-N-methylpyridin-2-amine

C12H17BrN2 (268.0575)


   

tetramethyllead

tetramethyllead

C4H12Pb (268.0705)


   

2-(11-oxo-6H-benzo[c][1]benzoxepin-3-yl)acetic acid

2-(11-oxo-6H-benzo[c][1]benzoxepin-3-yl)acetic acid

C16H12O4 (268.0736)


   

5-(Benzyloxy)-1H-indazole-3-carboxylic acid

5-(Benzyloxy)-1H-indazole-3-carboxylic acid

C15H12N2O3 (268.0848)


   

1-Bromo-3,5-di-tert-butybenzene

1-Bromo-3,5-di-tert-butylbenzene

C14H21Br (268.0827)


   

4-(chloromethyl)-1,3-diphenylpyrazole

4-(chloromethyl)-1,3-diphenylpyrazole

C16H13ClN2 (268.0767)


   

7-Methoxy-8-hydroxy-4-phenylcoumarin

7-Methoxy-8-hydroxy-4-phenylcoumarin

C16H12O4 (268.0736)


   

3-hydroxy-2-(2-methoxyphenyl)chromen-4-one

3-hydroxy-2-(2-methoxyphenyl)chromen-4-one

C16H12O4 (268.0736)


   

6-Methoxy-7-phenoxy-4(1H)-quinazolinone

6-Methoxy-7-phenoxy-4(1H)-quinazolinone

C15H12N2O3 (268.0848)


   

1-(3-Bromobenzyl)-4-methylpiperazine

1-(3-Bromobenzyl)-4-methylpiperazine

C12H17BrN2 (268.0575)


   

4-(ALLYL)-5-(QUINOL-6-YL)-1,2,4-TRIAZOLE-3-THIOL

4-(ALLYL)-5-(QUINOL-6-YL)-1,2,4-TRIAZOLE-3-THIOL

C14H12N4S (268.0783)


   

1-ACETYL-6,6-DIMETHYL-3-(METHYLTHIO)-4,5,6,7-TETRAHYDROBENZO[C]THIOPHEN-4-ONE

1-ACETYL-6,6-DIMETHYL-3-(METHYLTHIO)-4,5,6,7-TETRAHYDROBENZO[C]THIOPHEN-4-ONE

C13H16O2S2 (268.0592)


   

(2-(5-NITRO-1H-INDOL-2-YL)PHENYL)METHANOL

(2-(5-NITRO-1H-INDOL-2-YL)PHENYL)METHANOL

C15H12N2O3 (268.0848)


   

1-iodo-Decane

1-iodo-Decane

C10H21I (268.0688)


   

4-HYDROXY-5-METHOXYFLAVONE

4-HYDROXY-5-METHOXYFLAVONE

C16H12O4 (268.0736)


   

ALANINE RACEMASE

ALANINE RACEMASE

C11H12N2O6 (268.0695)


   

4-(2-Methylpropoxy)-1,3-benzenedicarbothioamide

4-(2-Methylpropoxy)-1,3-benzenedicarbothioamide

C12H16N2OS2 (268.0704)


   

Apotryptophanase from Escherichia coli

Apotryptophanase from Escherichia coli

C11H12N2O6 (268.0695)


   

1-vinyl-3-ethyliMidazoliuM hexafluorophosphate

1-vinyl-3-ethyliMidazoliuM hexafluorophosphate

C7H11F6N2P (268.0564)


   

4-(2-ethylhexyl)bromobenzene

4-(2-ethylhexyl)bromobenzene

C14H21Br (268.0827)


   

9,10-Anthracenedione,1,4-dihydroxy-2,3-dimethyl-

9,10-Anthracenedione,1,4-dihydroxy-2,3-dimethyl-

C16H12O4 (268.0736)


   

ethyl 2-[(2-chlorophenyl)hydrazinylidene]-3-oxo-butanoate

ethyl 2-[(2-chlorophenyl)hydrazinylidene]-3-oxo-butanoate

C12H13ClN2O3 (268.0615)


   

5-(6-METHOXYNAPHTHALEN-2-YL)-1H-PYRAZOLE-3-CARBOXYLIC ACID

5-(6-METHOXYNAPHTHALEN-2-YL)-1H-PYRAZOLE-3-CARBOXYLIC ACID

C15H12N2O3 (268.0848)


   

1-(3-bromophenyl)-N-methylpiperidin-4-amine

1-(3-bromophenyl)-N-methylpiperidin-4-amine

C12H17BrN2 (268.0575)


   

1-Chloro-4-(3,4-dimethylphenyl)phthalazine

1-Chloro-4-(3,4-dimethylphenyl)phthalazine

C16H13ClN2 (268.0767)


   

1-HYDROXY-2-METHOXY-3-METHYL-ANTHRAQUINONE

1-HYDROXY-2-METHOXY-3-METHYL-ANTHRAQUINONE

C16H12O4 (268.0736)


   

TERT-BUTYL 2-FORMYL-6,7-DIHYDROTHIAZOLO[5,4-C]PYRIDINE-5(4H)-CARBOXYLATE

TERT-BUTYL 2-FORMYL-6,7-DIHYDROTHIAZOLO[5,4-C]PYRIDINE-5(4H)-CARBOXYLATE

C12H16N2O3S (268.0882)


   

Isoxepac

Isoxepac

C16H12O4 (268.0736)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   

Amifostine trihydrate

Amifostine trihydrate

C5H21N2O6PS (268.0858)


C26170 - Protective Agent > C2459 - Chemoprotective Agent > C2080 - Cytoprotective Agent D020011 - Protective Agents > D011837 - Radiation-Protective Agents Amifostine trihydrate (WR2721 trihydrate) is a broad-spectrum cytoprotective agent and a radioprotector. Amifostine trihydrate selectively protects normal tissues from damage caused by radiation and chemotherapy. Amifostine trihydrate is potent hypoxia-inducible factor-α1 (HIF-α1) and p53 inducer. Amifostine trihydrate protects cells from damage by scavenging oxygen-derived free radicals. Amifostine trihydrate reduces renal toxicity and has antiangiogenic action[1][2][3][4].

   

2-BENZYLOXY-6-NITROMETHYLCYANOBENZENE

2-BENZYLOXY-6-NITROMETHYLCYANOBENZENE

C15H12N2O3 (268.0848)


   

5-(MORPHOLIN-4-YLSULFONYL)INDOLINE

5-(MORPHOLIN-4-YLSULFONYL)INDOLINE

C12H16N2O3S (268.0882)


   

1-(4-Bromobenzyl)-4-methylpiperazine

1-(4-Bromobenzyl)-4-methylpiperazine

C12H17BrN2 (268.0575)


   

4-(3,4-DIFLUOROPHENYL)-1,2,3,4-TETRAHYDRO-6-METHYL-2-OXO-5-PYRIMIDINECARBOXYLIC

4-(3,4-DIFLUOROPHENYL)-1,2,3,4-TETRAHYDRO-6-METHYL-2-OXO-5-PYRIMIDINECARBOXYLIC

C12H10F2N2O3 (268.0659)


   

Sodium N-acetyl-DL-tryptophanate

Sodium N-acetyl-DL-tryptophanate

C13H13N2NaO3 (268.0824)


   

tert-Butyl 3,5-dinitrobenzoate

tert-Butyl 3,5-dinitrobenzoate

C11H12N2O6 (268.0695)


   

(4-((4H-1,2,4-Triazol-4-yl)carbamoyl)phenyl)boronic acid hydrochloride

(4-((4H-1,2,4-Triazol-4-yl)carbamoyl)phenyl)boronic acid hydrochloride

C9H10BClN4O3 (268.0534)


   

Dazoxiben hydrochloride

Dazoxiben hydrochloride

C12H13ClN2O3 (268.0615)


C78275 - Agent Affecting Blood or Body Fluid > C29750 - Thrombolytic Agent D004791 - Enzyme Inhibitors

   

Tolpyrramide

Tolpyrramide

C12H16N2O3S (268.0882)


C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent

   

Deamino-beta-neuraminic acid

Deamino-beta-neuraminic acid

C9H16O9 (268.0794)


   

Deamino-alpha-neuraminic acid

Deamino-alpha-neuraminic acid

C9H16O9 (268.0794)


   

Cedazuridine

Cedazuridine

C9H14F2N2O5 (268.0871)


C471 - Enzyme Inhibitor > C2135 - Cytidine Deaminase Inhibitor

   
   

2-Amino-4-(3-amino-3-carboxypropyl)sulfonylbutanoic acid

2-Amino-4-(3-amino-3-carboxypropyl)sulfonylbutanoic acid

C8H16N2O6S (268.0729)


   

p-Hydroxy-p-methylphenytoin

p-Hydroxy-p-methylphenytoin

C15H12N2O3 (268.0848)


   

6-(2,5-Dioxotetrahydrofuran-3-yl)-4-methyltetrahydro-1H-furo[3,4-c]pyran-1,3(6H)-dione

6-(2,5-Dioxotetrahydrofuran-3-yl)-4-methyltetrahydro-1H-furo[3,4-c]pyran-1,3(6H)-dione

C12H12O7 (268.0583)


   

Tyrphostin A51

Tyrphostin A51

C13H8N4O3 (268.0596)


   

N-benzyl-7-chloroquinolin-4-amine

N-benzyl-7-chloroquinolin-4-amine

C16H13ClN2 (268.0767)


   

5-Pyridin-4-yl-4-o-tolyl-4H-[1,2,4]triazole-3-thiol

5-Pyridin-4-yl-4-o-tolyl-4H-[1,2,4]triazole-3-thiol

C14H12N4S (268.0783)


   

acetic acid (11-oxo-6H-benzo[c][1]benzoxepin-2-yl) ester

acetic acid (11-oxo-6H-benzo[c][1]benzoxepin-2-yl) ester

C16H12O4 (268.0736)


   

L-Cysteinyl-L-phenylalanine

L-Cysteinyl-L-phenylalanine

C12H16N2O3S (268.0882)


   

(2R)-3-Hydroxy-2-(beta-D-mannopyranosyloxy)propanoic acid

(2R)-3-Hydroxy-2-(beta-D-mannopyranosyloxy)propanoic acid

C9H16O9 (268.0794)


   

(5-Hydroxy-1-benzofuran-3-yl)(4-methoxyphenyl)methanone

(5-Hydroxy-1-benzofuran-3-yl)(4-methoxyphenyl)methanone

C16H12O4 (268.0736)


   

4H-1-Benzopyran-4-one, 2-(1,3-benzodioxol-5-yl)-2,3-dihydro-

4H-1-Benzopyran-4-one, 2-(1,3-benzodioxol-5-yl)-2,3-dihydro-

C16H12O4 (268.0736)


   

1H-Pyrimido[1,2-a]quinoline-2-carboxylic acid, 1-oxo-, ethyl ester

1H-Pyrimido[1,2-a]quinoline-2-carboxylic acid, 1-oxo-, ethyl ester

C15H12N2O3 (268.0848)


   

5-Phenylsulfanyl-2,4-quinazolinediamine

5-Phenylsulfanyl-2,4-quinazolinediamine

C14H12N4S (268.0783)


   

5-Imino-4-(3-trifluoromethyl-phenylazo)-5H-pyrazol-3-ylamine

5-Imino-4-(3-trifluoromethyl-phenylazo)-5H-pyrazol-3-ylamine

C10H7F3N6 (268.0684)


   

5-Imino-4-(2-trifluoromethyl-phenylazo)-5H-pyrazol-3-ylamine

5-Imino-4-(2-trifluoromethyl-phenylazo)-5H-pyrazol-3-ylamine

C10H7F3N6 (268.0684)


   

2-[(2,3,4-Trifluorobiphenyl-2-Yl)oxy]ethanol

2-[(2,3,4-Trifluorobiphenyl-2-Yl)oxy]ethanol

C14H11F3O2 (268.0711)


   

Furobufen

Furobufen

C16H12O4 (268.0736)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   

7-Hydroxy-3-(4-methoxyphenyl)chromen-2-one

7-Hydroxy-3-(4-methoxyphenyl)chromen-2-one

C16H12O4 (268.0736)


   

2-O-alpha-mannosyl-D-glycerate

2-O-alpha-mannosyl-D-glycerate

C9H16O9 (268.0794)


   
   

S-benzyl-L-cysteinylglycine

S-benzyl-L-cysteinylglycine

C12H16N2O3S (268.0882)


   

delta-N-(phosphonacetyl)-L-ornithine

delta-N-(phosphonacetyl)-L-ornithine

C7H15N3O6P- (268.0698)


   

[3,4,5,6-Tetrahydroxy-6-(hydroxymethyl)oxan-2-yl] 2-hydroxypropanoate

[3,4,5,6-Tetrahydroxy-6-(hydroxymethyl)oxan-2-yl] 2-hydroxypropanoate

C9H16O9 (268.0794)


   

[2,3,4,5-Tetrahydroxy-6-(hydroxymethyl)oxan-2-yl] 2-hydroxypropanoate

[2,3,4,5-Tetrahydroxy-6-(hydroxymethyl)oxan-2-yl] 2-hydroxypropanoate

C9H16O9 (268.0794)


   

4,4-Disulfanediylbis(2-ammoniobutanoate)

4,4-Disulfanediylbis(2-ammoniobutanoate)

C8H16N2O4S2 (268.0551)


   

N-(2-methyl-1,3-benzothiazol-6-yl)benzamide

N-(2-methyl-1,3-benzothiazol-6-yl)benzamide

C15H12N2OS (268.067)


   

N-(1,3-benzothiazol-2-yl)-N-methylbenzamide

N-(1,3-benzothiazol-2-yl)-N-methylbenzamide

C15H12N2OS (268.067)


   

1-Ethyl-3-[[[(phenylmethyl)amino]-sulfanylidenemethyl]amino]thiourea

1-Ethyl-3-[[[(phenylmethyl)amino]-sulfanylidenemethyl]amino]thiourea

C11H16N4S2 (268.0816)


   

4-(4-Phenylmethoxyphenyl)thiadiazole

4-(4-Phenylmethoxyphenyl)thiadiazole

C15H12N2OS (268.067)


   

5-(2-furanyl)-N-(4-methylphenyl)-3-isoxazolecarboxamide

5-(2-furanyl)-N-(4-methylphenyl)-3-isoxazolecarboxamide

C15H12N2O3 (268.0848)


   

1-(3-Hydroxy-2,4,4-trimethyl-1-oxido-5-thiophen-2-yl-2-imidazol-1-iumyl)ethanone

1-(3-Hydroxy-2,4,4-trimethyl-1-oxido-5-thiophen-2-yl-2-imidazol-1-iumyl)ethanone

C12H16N2O3S (268.0882)


   

Ethyl 2-oxobenzo[h]chromene-3-carboxylate

Ethyl 2-oxobenzo[h]chromene-3-carboxylate

C16H12O4 (268.0736)


   

2-(4-Methoxyphenyl)-2-oxoethyl Dithiobutyrate

2-(4-Methoxyphenyl)-2-oxoethyl Dithiobutyrate

C13H16O2S2 (268.0592)


   

1-Caproyl-sn-glycero-3-phosphate(2-)

1-Caproyl-sn-glycero-3-phosphate(2-)

C9H17O7P-2 (268.0712)


   

N-pyridin-4-yl-7,8-dihydro-6H-cyclopenta[4,5]thieno[1,2-c]pyrimidin-1-amine

N-pyridin-4-yl-7,8-dihydro-6H-cyclopenta[4,5]thieno[1,2-c]pyrimidin-1-amine

C14H12N4S (268.0783)


   

N-(2-oxo-6-pyrrol-1-ylchromen-3-yl)acetamide

N-(2-oxo-6-pyrrol-1-ylchromen-3-yl)acetamide

C15H12N2O3 (268.0848)


   

[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] 2,3-dihydroxypropanoate

[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] 2,3-dihydroxypropanoate

C9H16O9 (268.0794)


   

7-Hydroxy-8-methoxy-flavone

7-Hydroxy-8-methoxy-flavone

C16H12O4 (268.0736)


   

3-(6,7-Dimethoxy-1,3-benzodioxol-5-yl)oxirane-2-carboxylic acid

3-(6,7-Dimethoxy-1,3-benzodioxol-5-yl)oxirane-2-carboxylic acid

C12H12O7 (268.0583)


   

(R)-N-acetyl-S-benzyl-L-cysteine sulfoxide

(R)-N-acetyl-S-benzyl-L-cysteine sulfoxide

C12H14NO4S- (268.0644)


   

3-(2-Fluorophenyl)naphthalene-1,2,4-trione

3-(2-Fluorophenyl)naphthalene-1,2,4-trione

C16H9FO3 (268.0536)


   

Benzoic acid, 4-acetylthio-, trimethylsilyl ester

Benzoic acid, 4-acetylthio-, trimethylsilyl ester

C12H16O3SSi (268.0589)


   

Benzoic acid, 3-acetylthio-, trimethylsilyl ester

Benzoic acid, 3-acetylthio-, trimethylsilyl ester

C12H16O3SSi (268.0589)


   

5-Methoxy-6-hydroxyflavone

5-Methoxy-6-hydroxyflavone

C16H12O4 (268.0736)


   

Portulacaxanthin III

Portulacaxanthin III

C11H12N2O6 (268.0695)


   

6-[(1R)-1-hydroxyethyl]phenazine-1-carboxylic acid

6-[(1R)-1-hydroxyethyl]phenazine-1-carboxylic acid

C15H12N2O3 (268.0848)


   

Keto-Deoxy-Nonulonic acid

Keto-Deoxy-Nonulonic acid

C9H16O9 (268.0794)


   

Benzo(a)pyrene-11,12-epoxide

Benzo(a)pyrene-11,12-epoxide

C20H12O (268.0888)


   

Benzo[a]pyrene-4,5-oxide

Benzo[a]pyrene-4,5-epoxide

C20H12O (268.0888)


D009676 - Noxae > D002273 - Carcinogens

   

L,L-homocystine zwitterion

L,L-homocystine zwitterion

C8H16N2O4S2 (268.0551)


   

3-deoxy-D-glycero-beta-D-galacto-nonulosonic acid

3-deoxy-D-glycero-beta-D-galacto-nonulosonic acid

C9H16O9 (268.0794)


A deaminoneuraminic acid in which the anomeric centre has beta-configuration.

   

5-(4-Hydroxyphenyl)-5-phenylimidazolidine-2,4-dione

2,4-Imidazolidinedione,5-(4-hydroxyphenyl)-5-phenyl-

C15H12N2O3 (268.0848)


   

9-Hydroxybenzo[a]pyrene

9-Hydroxybenzo[a]pyrene

C20H12O (268.0888)


   

(2S)-2-amino-4-[(3-amino-3-carboxypropyl)disulfanyl]butanoic acid

(2S)-2-amino-4-[(3-amino-3-carboxypropyl)disulfanyl]butanoic acid

C8H16N2O4S2 (268.0551)


   

3-Hydroxybenzo[a]pyrene

3-Hydroxybenzo[a]pyrene

C20H12O (268.0888)


   

Benzo[a]pyrene-7,8-oxide

Benzo[a]pyrene-7,8-epoxide

C20H12O (268.0888)


   

2,3-Dihydroxycarbamazepine

2,3-Dihydroxycarbamazepine

C15H12N2O3 (268.0848)


   

Cysteinyl-Phenylalanine

Cysteinyl-Phenylalanine

C12H16N2O3S (268.0882)


   

Benzo[a]pyrene-9,10-oxide

Benzo[a]pyrene-9,10-epoxide

C20H12O (268.0888)


   

Phenytoin arene-oxide

Phenytoin arene-oxide

C15H12N2O3 (268.0848)


   

(5R)-5-(3-hydroxyphenyl)-5-phenylimidazolidine-2,4-dione

(5R)-5-(3-hydroxyphenyl)-5-phenylimidazolidine-2,4-dione

C15H12N2O3 (268.0848)


   

[3-(hexanoyloxy)-2-oxopropoxy]phosphonic acid

[3-(hexanoyloxy)-2-oxopropoxy]phosphonic acid

C9H17O7P (268.0712)


   

Phenylalanylcysteine

Phenylalanylcysteine

C12H16N2O3S (268.0882)


   

1-Caproyl-sn-glycero-3-phosphate(2-)

1-Caproyl-sn-glycero-3-phosphate(2-)

C9H17O7P (268.0712)


A 1-acyl-sn-glycero-3-phosphate(2-) in which the acyl group is specified as caproyl (hexanoyl).

   

6-Hydroxy-2-(4-hydroxyphenyl)-3-benzofuranyl methyl ketone

1-(6-Hydroxy-2-(4-hydroxyphenyl)-1-benzofuran-3-yl)ethanone

C16H12O4 (268.0736)


   

4-Hydroxyphenytoin

4-Hydroxyphenytoin

C15H12N2O3 (268.0848)


A imidazolidine-2,4-dione that consists of hydantoin bearing phenyl and 4-hydroxyphenyl substituents at position 5.

   

homocystine zwitterion

homocystine zwitterion

C8H16N2O4S2 (268.0551)


Dizwitterionic form of homocystine arising from transfer of two protons from the carboxy to the amino groups; major species at pH 7.3.

   

2-(alpha-D-mannosyl)-D-glyceric acid

2-(alpha-D-mannosyl)-D-glyceric acid

C9H16O9 (268.0794)


A D-mannosyl-D-glyceric acid where an alpha-D-mannosyl residue is attached at the 2-position.

   

Mannosyl-glyceric acid

Mannosyl-glyceric acid

C9H16O9 (268.0794)


   

Deoxy-glycero-galactononulosonic acid

Deoxy-glycero-galactononulosonic acid

C9H16O9 (268.0794)


   

1,4-DPCA ethyl ester

1,4-DPCA ethyl ester

C15H12N2O3 (268.0848)


1,4-DPCA ethyl ester is the ethyl ester of 1,4-DPCA and can inhibit factor inhibiting HIF (FIH)[1].

   

3-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2h,6h-pyrazolo[4,3-d]pyrimidin-7-one

3-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2h,6h-pyrazolo[4,3-d]pyrimidin-7-one

C10H12N4O5 (268.0808)


   

(3e)-7-hydroxy-3-[(4-hydroxyphenyl)methylidene]-2h-1-benzopyran-4-one

(3e)-7-hydroxy-3-[(4-hydroxyphenyl)methylidene]-2h-1-benzopyran-4-one

C16H12O4 (268.0736)


   

5-hydroxy-2-(2-methoxyphenyl)chromen-4-one

5-hydroxy-2-(2-methoxyphenyl)chromen-4-one

C16H12O4 (268.0736)


   

2-hydroxy-1-methoxy-7-methylanthracene-9,10-dione

2-hydroxy-1-methoxy-7-methylanthracene-9,10-dione

C16H12O4 (268.0736)


   

(3s,4r,5r)-2-(6-hydroxy-9h-purin-2-yl)oxane-3,4,5-triol

(3s,4r,5r)-2-(6-hydroxy-9h-purin-2-yl)oxane-3,4,5-triol

C10H12N4O5 (268.0808)


   

2-(6-hydroxypurin-9-yl)oxane-3,4,5-triol

2-(6-hydroxypurin-9-yl)oxane-3,4,5-triol

C10H12N4O5 (268.0808)


   

8-hydroxy-3-(4-hydroxyphenyl)-7-methylchromen-4-one

8-hydroxy-3-(4-hydroxyphenyl)-7-methylchromen-4-one

C16H12O4 (268.0736)


   

3-hydroxy-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propanoic acid

3-hydroxy-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propanoic acid

C9H16O9 (268.0794)


   

4-hydroxy-3-methoxy-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-5,7,9(16),10(15),11,13-hexaen-2-one

4-hydroxy-3-methoxy-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-5,7,9(16),10(15),11,13-hexaen-2-one

C15H12N2O3 (268.0848)


   

(3s,4s)-4-hydroxy-3-methoxy-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-5,7,9(16),10(15),11,13-hexaen-2-one

(3s,4s)-4-hydroxy-3-methoxy-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-5,7,9(16),10(15),11,13-hexaen-2-one

C15H12N2O3 (268.0848)


   

1-hydroxy-3-methoxy-6-methylanthracene-9,10-dione

1-hydroxy-3-methoxy-6-methylanthracene-9,10-dione

C16H12O4 (268.0736)


   

(12s)-4-hydroxy-11-oxatetracyclo[8.7.0.0³,⁸.0¹²,¹⁶]heptadeca-1(10),3,5,7,16-pentaene-2,9-dione

(12s)-4-hydroxy-11-oxatetracyclo[8.7.0.0³,⁸.0¹²,¹⁶]heptadeca-1(10),3,5,7,16-pentaene-2,9-dione

C16H12O4 (268.0736)


   

1-hydroxy-2-methoxy-7-methylanthracene-9,10-dione

1-hydroxy-2-methoxy-7-methylanthracene-9,10-dione

C16H12O4 (268.0736)


   

5-methoxy-2-oxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(14),4,6,8(16),9,11(15),12-heptaene-6,13-diol

5-methoxy-2-oxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(14),4,6,8(16),9,11(15),12-heptaene-6,13-diol

C16H12O4 (268.0736)


   

1-hydroxy-4-methoxy-2-methylanthracene-9,10-dione

1-hydroxy-4-methoxy-2-methylanthracene-9,10-dione

C16H12O4 (268.0736)


   

1, 3-dihydroxy-2-methylanthraguinone

NA

C16H12O4 (268.0736)


{"Ingredient_id": "HBIN001186","Ingredient_name": "1, 3-dihydroxy-2-methylanthraguinone","Alias": "NA","Ingredient_formula": "C16H12O4","Ingredient_Smile": "CC1=C(C=C2C(=C1OC)C(=O)C3=CC=CC=C3C2=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41923","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

1-hydroxy-3-methoxy-2-methylanthraquinone

NA

C16H12O4 (268.0736)


{"Ingredient_id": "HBIN002634","Ingredient_name": "1-hydroxy-3-methoxy-2-methylanthraquinone","Alias": "NA","Ingredient_formula": "C16H12O4","Ingredient_Smile": "CC1=C(C2=C(C=C1)C(=O)C3=C(C2=O)C=CC(=C3)O)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10413","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

1-hydroxy-5-methoxy-2-methylanthraquinone

NA

C16H12O4 (268.0736)


{"Ingredient_id": "HBIN002639","Ingredient_name": "1-hydroxy-5-methoxy-2-methylanthraquinone","Alias": "NA","Ingredient_formula": "C16H12O4","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10414","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

6-isoinosine

NA

C10H12N4O5 (268.0808)


{"Ingredient_id": "HBIN012477","Ingredient_name": "6-isoinosine","Alias": "NA","Ingredient_formula": "C10H12N4O5","Ingredient_Smile": "C1=NC(=O)NC2=C1N=CN2C3C(C(C(O3)CO)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "11462","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

7-hydroxy-3-(4-hydroxybenzylidene)-4-chromanone

NA

C16H12O4 (268.0736)


{"Ingredient_id": "HBIN013223","Ingredient_name": "7-hydroxy-3-(4-hydroxybenzylidene)-4-chromanone","Alias": "NA","Ingredient_formula": "C16H12O4","Ingredient_Smile": "C1C(=CC2=CC=C(C=C2)O)C(=O)C3=C(O1)C=C(C=C3)O","Ingredient_weight": "268.26","OB_score": "NA","CAS_id": "110064-50-1","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7454","PubChem_id": "44443280","DrugBank_id": "NA"}

   

methyl 4-oxo-2-(1h-pyrrol-2-yl)-1h-quinoline-3-carboxylate

methyl 4-oxo-2-(1h-pyrrol-2-yl)-1h-quinoline-3-carboxylate

C15H12N2O3 (268.0848)


   

3,4,8,9-tetrahydro-2,7-dioxatetraphene-1,6-dione

3,4,8,9-tetrahydro-2,7-dioxatetraphene-1,6-dione

C16H12O4 (268.0736)


   

2-ethoxy-1-hydroxyanthracene-9,10-dione

2-ethoxy-1-hydroxyanthracene-9,10-dione

C16H12O4 (268.0736)


   

16,16-dimethyl-3,8,17-trioxatetracyclo[11.4.0.0²,⁶.0⁷,¹²]heptadeca-1(13),2(6),4,7(12),10,14-hexaen-9-one

16,16-dimethyl-3,8,17-trioxatetracyclo[11.4.0.0²,⁶.0⁷,¹²]heptadeca-1(13),2(6),4,7(12),10,14-hexaen-9-one

C16H12O4 (268.0736)


   

5-hydroxy-2-(3-methoxyphenyl)chromen-4-one

5-hydroxy-2-(3-methoxyphenyl)chromen-4-one

C16H12O4 (268.0736)


   

4-hydroxy-11-oxatetracyclo[8.7.0.0³,⁸.0¹²,¹⁶]heptadeca-1(10),3,5,7,16-pentaene-2,9-dione

4-hydroxy-11-oxatetracyclo[8.7.0.0³,⁸.0¹²,¹⁶]heptadeca-1(10),3,5,7,16-pentaene-2,9-dione

C16H12O4 (268.0736)


   

1-hydroxy-7-methoxy-2-methylanthracene-9,10-dione

1-hydroxy-7-methoxy-2-methylanthracene-9,10-dione

C16H12O4 (268.0736)


   

6-hydroxy-2-(4-methoxyphenyl)chromen-4-one

6-hydroxy-2-(4-methoxyphenyl)chromen-4-one

C16H12O4 (268.0736)


   

3-hydroxy-8-methoxy-1-methylanthracene-9,10-dione

3-hydroxy-8-methoxy-1-methylanthracene-9,10-dione

C16H12O4 (268.0736)


   

5-methoxy-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1(10),2,4,6,11,13,15-heptaen-14-ol

5-methoxy-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1(10),2,4,6,11,13,15-heptaen-14-ol

C16H12O4 (268.0736)


   

methyl 3-[3-formyl-5-(hydroxymethyl)-4-methoxy-6-oxopyran-2-yl]prop-2-enoate

methyl 3-[3-formyl-5-(hydroxymethyl)-4-methoxy-6-oxopyran-2-yl]prop-2-enoate

C12H12O7 (268.0583)


   

3-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-2,4-dihydroxybutanoic acid

3-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-2,4-dihydroxybutanoic acid

C9H16O9 (268.0794)


   

14-hydroxy-13-methoxy-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-5,7,9(16),10(15),11,13-hexaen-2-one

14-hydroxy-13-methoxy-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-5,7,9(16),10(15),11,13-hexaen-2-one

C15H12N2O3 (268.0848)


   

7-hydroxy-3-(4-hydroxyphenyl)-8-methylchromen-4-one

7-hydroxy-3-(4-hydroxyphenyl)-8-methylchromen-4-one

C16H12O4 (268.0736)


   

(2r,3r)-3-{[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-2,4-dihydroxybutanoic acid

(2r,3r)-3-{[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-2,4-dihydroxybutanoic acid

C9H16O9 (268.0794)


   

1-hydroxy-6-methoxy-3-methylanthracene-9,10-dione

1-hydroxy-6-methoxy-3-methylanthracene-9,10-dione

C16H12O4 (268.0736)


   

9-hydroxybenzo(a)pyrene

9-hydroxybenzo(a)pyrene

C20H12O (268.0888)


   

7-hydroxy-3-[(4-hydroxyphenyl)methyl]chromen-4-one

7-hydroxy-3-[(4-hydroxyphenyl)methyl]chromen-4-one

C16H12O4 (268.0736)


   

1-hydroxy-2-methoxy-6-methylanthracene-9,10-dione

1-hydroxy-2-methoxy-6-methylanthracene-9,10-dione

C16H12O4 (268.0736)


   

6,8-dihydroxy-2-(4-hydroxyphenyl)-4h-naphthalen-1-one

6,8-dihydroxy-2-(4-hydroxyphenyl)-4h-naphthalen-1-one

C16H12O4 (268.0736)


   

1-hydroxy-7-methoxy-3-methylanthracene-9,10-dione

1-hydroxy-7-methoxy-3-methylanthracene-9,10-dione

C16H12O4 (268.0736)


   

methyl 4-formyl-2-(hydroxymethyl)-5-[(1e)-3-methoxy-3-oxoprop-1-en-1-yl]furan-3-carboxylate

methyl 4-formyl-2-(hydroxymethyl)-5-[(1e)-3-methoxy-3-oxoprop-1-en-1-yl]furan-3-carboxylate

C12H12O7 (268.0583)


   

11-methoxy-9h-phenanthro[2,3-d][1,3]dioxol-3-ol

11-methoxy-9h-phenanthro[2,3-d][1,3]dioxol-3-ol

C16H12O4 (268.0736)


   

(2r,3r,4r,5r)-2-(6-hydroxypurin-9-yl)oxane-3,4,5-triol

(2r,3r,4r,5r)-2-(6-hydroxypurin-9-yl)oxane-3,4,5-triol

C10H12N4O5 (268.0808)


   

5-hydroxy-2-(4-hydroxyphenyl)-7-methylchromen-4-one

5-hydroxy-2-(4-hydroxyphenyl)-7-methylchromen-4-one

C16H12O4 (268.0736)


   

8-hydroxy-13-methoxy-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-5,7,9(16),10(15),11,13-hexaen-2-one

8-hydroxy-13-methoxy-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-5,7,9(16),10(15),11,13-hexaen-2-one

C15H12N2O3 (268.0848)


   

(2s,4s,5r,6r)-2,4,5-trihydroxy-6-[(1r,2r)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid

(2s,4s,5r,6r)-2,4,5-trihydroxy-6-[(1r,2r)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid

C9H16O9 (268.0794)


   

(2s)-4-[(1e)-2-[(carboxymethyl)amino]ethenyl]-2,3-dihydropyridine-2,6-dicarboxylic acid

(2s)-4-[(1e)-2-[(carboxymethyl)amino]ethenyl]-2,3-dihydropyridine-2,6-dicarboxylic acid

C11H12N2O6 (268.0695)


   

1,8-dihydroxy-3,6-dimethylanthracene-9,10-dione

1,8-dihydroxy-3,6-dimethylanthracene-9,10-dione

C16H12O4 (268.0736)


   

2,4,5-trihydroxy-6-(1,2,3-trihydroxypropyl)oxane-2-carboxylic acid

2,4,5-trihydroxy-6-(1,2,3-trihydroxypropyl)oxane-2-carboxylic acid

C9H16O9 (268.0794)


   

methyl (2e)-3-[3-formyl-5-(hydroxymethyl)-4-methoxy-6-oxopyran-2-yl]prop-2-enoate

methyl (2e)-3-[3-formyl-5-(hydroxymethyl)-4-methoxy-6-oxopyran-2-yl]prop-2-enoate

C12H12O7 (268.0583)


   

n-{2-[(2-{[hydroxy(methoxy)methylidene]amino}ethyl)disulfanyl]ethyl}methoxycarboximidic acid

n-{2-[(2-{[hydroxy(methoxy)methylidene]amino}ethyl)disulfanyl]ethyl}methoxycarboximidic acid

C8H16N2O4S2 (268.0551)


   

(2r)-3-hydroxy-2-{[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propanoic acid

(2r)-3-hydroxy-2-{[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propanoic acid

C9H16O9 (268.0794)


   

7-hydroxy-4-(4-methoxyphenyl)chromen-2-one

7-hydroxy-4-(4-methoxyphenyl)chromen-2-one

C16H12O4 (268.0736)


   

5,6-dihydroxy-3-(hydroxymethyl)-2-oxocyclohex-3-en-1-yl furan-2-carboxylate

5,6-dihydroxy-3-(hydroxymethyl)-2-oxocyclohex-3-en-1-yl furan-2-carboxylate

C12H12O7 (268.0583)


   

(2s,4z)-4-{2-[(carboxymethyl)imino]ethylidene}-2,3-dihydro-1h-pyridine-2,6-dicarboxylic acid

(2s,4z)-4-{2-[(carboxymethyl)imino]ethylidene}-2,3-dihydro-1h-pyridine-2,6-dicarboxylic acid

C11H12N2O6 (268.0695)


   

(2e)-3-{7-methoxy-9h-pyrido[3,4-b]indol-1-yl}prop-2-enoic acid

(2e)-3-{7-methoxy-9h-pyrido[3,4-b]indol-1-yl}prop-2-enoic acid

C15H12N2O3 (268.0848)


   

8-hydroxy-3-methoxy-1-methylanthracene-9,10-dione

8-hydroxy-3-methoxy-1-methylanthracene-9,10-dione

C16H12O4 (268.0736)


   

1-hydroxy-3-methoxy-2-methylanthracene-9,10-dione

1-hydroxy-3-methoxy-2-methylanthracene-9,10-dione

C16H12O4 (268.0736)


   

5,7-dihydroxy-8-methyl-2-phenylchromen-4-one

5,7-dihydroxy-8-methyl-2-phenylchromen-4-one

C16H12O4 (268.0736)


   

7-hydroxy-3-[(4-hydroxyphenyl)methylidene]-2h-1-benzopyran-4-one

7-hydroxy-3-[(4-hydroxyphenyl)methylidene]-2h-1-benzopyran-4-one

C16H12O4 (268.0736)


   

methyl 4-methoxyphenazine-1-carboxylate

methyl 4-methoxyphenazine-1-carboxylate

C15H12N2O3 (268.0848)


   

1-hydroxy-5-methoxy-3-methylanthracene-9,10-dione

1-hydroxy-5-methoxy-3-methylanthracene-9,10-dione

C16H12O4 (268.0736)


   

3-hydroxy-2-(4-methoxyphenyl)chromen-4-one

3-hydroxy-2-(4-methoxyphenyl)chromen-4-one

C16H12O4 (268.0736)


   

methyl 6-methoxyphenazine-1-carboxylate

methyl 6-methoxyphenazine-1-carboxylate

C15H12N2O3 (268.0848)


   

(1s)-14-methoxy-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-2,4,6,9,11,13,15-heptaen-5-ol

(1s)-14-methoxy-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-2,4,6,9,11,13,15-heptaen-5-ol

C16H12O4 (268.0736)


   

3-hydroxy-2-methoxy-6-methylanthracene-9,10-dione

3-hydroxy-2-methoxy-6-methylanthracene-9,10-dione

C16H12O4 (268.0736)


   

6-hydroxy-1-methoxy-2-methylanthracene-9,10-dione

6-hydroxy-1-methoxy-2-methylanthracene-9,10-dione

C16H12O4 (268.0736)


   

methyl 9-methoxyphenazine-1-carboxylate

methyl 9-methoxyphenazine-1-carboxylate

C15H12N2O3 (268.0848)


   

(2r,3s,4r,5r)-2-(hydroxymethyl)-5-{4-hydroxypyrazolo[3,4-d]pyrimidin-1-yl}oxolane-3,4-diol

(2r,3s,4r,5r)-2-(hydroxymethyl)-5-{4-hydroxypyrazolo[3,4-d]pyrimidin-1-yl}oxolane-3,4-diol

C10H12N4O5 (268.0808)


   

6-hydroxy-13-methoxy-2-oxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4(16),5,7,11,13-hexaen-3-one

6-hydroxy-13-methoxy-2-oxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4(16),5,7,11,13-hexaen-3-one

C16H12O4 (268.0736)


   

3-hydroxy-7-methoxy-2-phenylchromen-4-one

3-hydroxy-7-methoxy-2-phenylchromen-4-one

C16H12O4 (268.0736)


   

7-hydroxy-8-methoxy-6-methylanthracene-1,2-dione

7-hydroxy-8-methoxy-6-methylanthracene-1,2-dione

C16H12O4 (268.0736)


   

(2s)-3-hydroxy-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propanoic acid

(2s)-3-hydroxy-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propanoic acid

C9H16O9 (268.0794)


   

(1s,5r,6r)-5,6-dihydroxy-3-(hydroxymethyl)-2-oxocyclohex-3-en-1-yl furan-2-carboxylate

(1s,5r,6r)-5,6-dihydroxy-3-(hydroxymethyl)-2-oxocyclohex-3-en-1-yl furan-2-carboxylate

C12H12O7 (268.0583)


   

5-hydroxy-7-methoxy-3-phenylchromen-4-one

5-hydroxy-7-methoxy-3-phenylchromen-4-one

C16H12O4 (268.0736)


   

2-(4-hydroxyphenyl)-5-methoxychromen-4-one

2-(4-hydroxyphenyl)-5-methoxychromen-4-one

C16H12O4 (268.0736)


   

6-hydroxy-7-methoxy-3-phenylchromen-2-one

6-hydroxy-7-methoxy-3-phenylchromen-2-one

C16H12O4 (268.0736)